Tiramisu2020的个人主页 - 老虎社区

Tiramisu2020

Tiramisu2020

暂无个人介绍

IP属地：未知

309关注

23粉丝

0主题

0勋章

2022-04-22

I am happy with investing

2022-04-21

Hope market is good

2022-03-27

Cool

抱歉，原内容已删除

2022-02-19

cool

抱歉，原内容已删除

2022-02-18

cool

抱歉，原内容已删除

2022-02-18

Cool

5 Stocks To Watch For February 18, 2022

2022-02-17

Cool

@zhuzhu518:$NVIDIA Corp(NVDA)$有没有可能跟特斯拉一样，财报凶猛但是结局惨淡?

2022-02-16

like

抱歉，原内容已删除

2022-02-16

like

抱歉，原内容已删除

2022-02-16

like

Apple, Amazon, Microsoft or Tesla: Which Will Reach $5 Trillion First?

2022-02-08

Cool

抱歉，原内容已删除

2022-02-07

Cool

抱歉，原内容已删除

2022-01-29

Cool

Why Mastercard Stock Blasted 9% Higher Today

2022-01-20

Cool

Cathie Wood's Ark Trims Exposure In Netflix Ahead Of Earnings Report

2022-01-19

cool

Tesla Q4 Earnings Are Coming - What To Expect

2022-01-17

Like

Moderna: High Upside Potential At Current Prices

2022-01-17

cool

抱歉，原内容已删除

2022-01-17

cool

抱歉，原内容已删除

2022-01-17

Great ariticle, would you like to share it?

@言财美股研究社:加息与缩表会是决定价值股跑赢科技成长股的信号枪吗？

2022-01-17

Great ariticle, would you like to share it?

@话题虎:“女巴菲特”彻底栽了，木头姐一年回撤40%！仍然再加仓！

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"4089812543711440","uuid":"4089812543711440","gmtCreate":1626711205087,"gmtModify":1626750392993,"name":"Tiramisu2020","pinyin":"tiramisu2020","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/c7923aecbb67682b46eed9d583bc08c3","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":23,"headSize":309,"tweetSize":192,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.10.19","exceedPercentage":"60.65%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.12.02","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":3,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":611743825,"gmtCreate":1650642441912,"gmtModify":1650642442240,"author":{"id":"4089812543711440","authorId":"4089812543711440","name":"Tiramisu2020","avatar":"https://static.tigerbbs.com/c7923aecbb67682b46eed9d583bc08c3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089812543711440","authorIdStr":"4089812543711440"},"themes":[],"htmlText":"I am happy with investing","listText":"I am happy with investing","text":"I am happy with investing","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/611743825","isVote":1,"tweetType":1,"viewCount":1355,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":611571040,"gmtCreate":1650556114686,"gmtModify":1650556115072,"author":{"id":"4089812543711440","authorId":"4089812543711440","name":"Tiramisu2020","avatar":"https://static.tigerbbs.com/c7923aecbb67682b46eed9d583bc08c3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089812543711440","authorIdStr":"4089812543711440"},"themes":[],"htmlText":"Hope market is good","listText":"Hope market is good","text":"Hope market is good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/611571040","isVote":1,"tweetType":1,"viewCount":1219,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":637773149,"gmtCreate":1648366303691,"gmtModify":1648366304005,"author":{"id":"4089812543711440","authorId":"4089812543711440","name":"Tiramisu2020","avatar":"https://static.tigerbbs.com/c7923aecbb67682b46eed9d583bc08c3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089812543711440","authorIdStr":"4089812543711440"},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/637773149","repostId":"2222859475","repostType":2,"isVote":1,"tweetType":1,"viewCount":1377,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":638676941,"gmtCreate":1645282282721,"gmtModify":1645282283011,"author":{"id":"4089812543711440","authorId":"4089812543711440","name":"Tiramisu2020","avatar":"https://static.tigerbbs.com/c7923aecbb67682b46eed9d583bc08c3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089812543711440","authorIdStr":"4089812543711440"},"themes":[],"htmlText":"cool","listText":"cool","text":"cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/638676941","repostId":"1169107504","repostType":2,"isVote":1,"tweetType":1,"viewCount":955,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":638852001,"gmtCreate":1645186562613,"gmtModify":1645186562942,"author":{"id":"4089812543711440","authorId":"4089812543711440","name":"Tiramisu2020","avatar":"https://static.tigerbbs.com/c7923aecbb67682b46eed9d583bc08c3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089812543711440","authorIdStr":"4089812543711440"},"themes":[],"htmlText":"cool","listText":"cool","text":"cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/638852001","repostId":"2212623802","repostType":4,"isVote":1,"tweetType":1,"viewCount":1131,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":638856422,"gmtCreate":1645186507370,"gmtModify":1645186517058,"author":{"id":"4089812543711440","authorId":"4089812543711440","name":"Tiramisu2020","avatar":"https://static.tigerbbs.com/c7923aecbb67682b46eed9d583bc08c3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089812543711440","authorIdStr":"4089812543711440"},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/638856422","repostId":"2212623802","repostType":4,"repost":{"id":"2212623802","kind":"highlight","pubTimestamp":1645174559,"share":"https://www.laohu8.com/m/news/2212623802?lang=&edition=full","pubTime":"2022-02-18 16:55","market":"us","language":"en","title":"5 Stocks To Watch For February 18, 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=2212623802","media":"Benzinga","summary":"Some of the stocks that may grab investor focus today are:","content":"<html><head></head><body><p>Some of the stocks that may grab investor focus today are:</p><ul><li>Wall Street expects <b> </b><a href=\"https://laohu8.com/S/DE\">Deere & Company </a> to report quarterly earnings at $2.26 per share on revenue of $8.19 billion before the opening bell. Deere shares fell 0.3% to $379.50 in after-hours trading.</li><li><a href=\"https://laohu8.com/S/DBX\">Dropbox, Inc. </a> reported better-than-expected earnings and sales results for its fourth quarter. Dropbox shares, however, fell 5.4% to $22.30 in the after-hours trading session.</li><li>Analysts are expecting <b> </b><a href=\"https://laohu8.com/S/PPL\">PPL Corporation </a> to have earned $0.32 per share on revenue of $2.00 billion for the latest quarter. The company will release earnings before the markets open. PPL shares gained 0.5% to $28.28 in after-hours trading.</li></ul><ul><li><a href=\"https://laohu8.com/S/ROKU\">Roku, Inc. </a> posted downbeat revenue for its fourth quarter and issued weak sales forecast for the first quarter. Roku shares dipped 22.4% to $112.32 in the after-hours trading session.</li><li>Analysts expect <a href=\"https://laohu8.com/S/BLMN\">Bloomin</a><b> </b>to report quarterly earnings at $0.52 per share on revenue of $1.04 billion before the opening bell. Bloomin' Brands shares rose 0.5% to $22.60 in after-hours trading.</li></ul><p></p></body></html>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>5 Stocks To Watch For February 18, 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Stocks To Watch For February 18, 2022\n</h2>\n<h4 class=\"meta\">\n\n\n2022-02-18 16:55 GMT+8   <a href=\"https://www.benzinga.com/news/earnings/22/02/25709284/5-stocks-to-watch-for-february-18-2022\"><strong>Benzinga</strong></a>\n</h4>\n</header>\n<article>\n<div>\n<p>Some of the stocks that may grab investor focus today are:Wall Street expects  Deere & Company  to report quarterly earnings at $2.26 per share on revenue of $8.19 billion before the opening bell. ...</p>\n<a href=\"https://www.benzinga.com/news/earnings/22/02/25709284/5-stocks-to-watch-for-february-18-2022\">Web Link</a>\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ROKU":"Roku Inc","OLPX":"Olaplex Holdings, Inc.","BK4528":"SaaS概念","BK4516":"特朗普概念","BK4539":"次新股","BLMN":"Bloomin' Brands","BK4023":"应用软件","BK4187":"航天航空与国防","BK4532":"文艺复兴科技持仓","BK4564":"太空概念","BK4191":"家用电器","BK4108":"电影和娱乐","FWRG":"First Watch Restaurant Group, Inc.","BK4534":"瑞士信贷持仓","BK4507":"流媒体概念","BK4007":"制药","BK4524":"宅经济概念","DBX":"Dropbox Inc.","BK4152":"农用农业机械","CRCT":"Cricut, Inc.","BK4167":"医疗保健技术","BK4081":"电力公用事业","DE":"迪尔股份有限公司","HCTI":"Healthcare Triangle, Inc.","BK4551":"寇图资本持仓","BA":"波音","PPL":"宾州电力","BK4209":"餐馆","BK4183":"个人用品","TERN":"Terns Pharmaceuticals, Inc.","BK4548":"巴美列捷福持仓"},"source_url":"https://www.benzinga.com/news/earnings/22/02/25709284/5-stocks-to-watch-for-february-18-2022","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2212623802","content_text":"Some of the stocks that may grab investor focus today are:Wall Street expects  Deere & Company  to report quarterly earnings at $2.26 per share on revenue of $8.19 billion before the opening bell. Deere shares fell 0.3% to $379.50 in after-hours trading.Dropbox, Inc.  reported better-than-expected earnings and sales results for its fourth quarter. Dropbox shares, however, fell 5.4% to $22.30 in the after-hours trading session.Analysts are expecting  PPL Corporation  to have earned $0.32 per share on revenue of $2.00 billion for the latest quarter. The company will release earnings before the markets open. PPL shares gained 0.5% to $28.28 in after-hours trading.Roku, Inc.  posted downbeat revenue for its fourth quarter and issued weak sales forecast for the first quarter. Roku shares dipped 22.4% to $112.32 in the after-hours trading session.Analysts expect Bloomin to report quarterly earnings at $0.52 per share on revenue of $1.04 billion before the opening bell. Bloomin' Brands shares rose 0.5% to $22.60 in after-hours trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1303,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":638376996,"gmtCreate":1645100294556,"gmtModify":1645100361212,"author":{"id":"4089812543711440","authorId":"4089812543711440","name":"Tiramisu2020","avatar":"https://static.tigerbbs.com/c7923aecbb67682b46eed9d583bc08c3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089812543711440","authorIdStr":"4089812543711440"},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/638376996","repostId":"638079629","repostType":1,"repost":{"id":638079629,"gmtCreate":1645005301607,"gmtModify":1645052960492,"author":{"id":"3573593808442035","authorId":"3573593808442035","name":"zhuzhu518","avatar":"https://static.tigerbbs.com/272cc270b288063fa925b5f2c1a0bb76","crmLevel":9,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3573593808442035","authorIdStr":"3573593808442035"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/NVDA\">$NVIDIA Corp(NVDA)$</a>有没有可能跟特斯拉一样，财报凶猛但是结局惨淡?","listText":"<a href=\"https://laohu8.com/S/NVDA\">$NVIDIA Corp(NVDA)$</a>有没有可能跟特斯拉一样，财报凶猛但是结局惨淡?","text":"$NVIDIA Corp(NVDA)$有没有可能跟特斯拉一样，财报凶猛但是结局惨淡?","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/638079629","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":1489,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":638991819,"gmtCreate":1645015059095,"gmtModify":1645015059401,"author":{"id":"4089812543711440","authorId":"4089812543711440","name":"Tiramisu2020","avatar":"https://static.tigerbbs.com/c7923aecbb67682b46eed9d583bc08c3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089812543711440","authorIdStr":"4089812543711440"},"themes":[],"htmlText":"like","listText":"like","text":"like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/638991819","repostId":"2211165264","repostType":4,"isVote":1,"tweetType":1,"viewCount":1153,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":638993495,"gmtCreate":1645014886333,"gmtModify":1645014886604,"author":{"id":"4089812543711440","authorId":"4089812543711440","name":"Tiramisu2020","avatar":"https://static.tigerbbs.com/c7923aecbb67682b46eed9d583bc08c3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089812543711440","authorIdStr":"4089812543711440"},"themes":[],"htmlText":"like","listText":"like","text":"like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/638993495","repostId":"1161161615","repostType":4,"isVote":1,"tweetType":1,"viewCount":1183,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":638993208,"gmtCreate":1645014870802,"gmtModify":1645014871080,"author":{"id":"4089812543711440","authorId":"4089812543711440","name":"Tiramisu2020","avatar":"https://static.tigerbbs.com/c7923aecbb67682b46eed9d583bc08c3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089812543711440","authorIdStr":"4089812543711440"},"themes":[],"htmlText":"like","listText":"like","text":"like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/638993208","repostId":"1161161615","repostType":4,"repost":{"id":"1161161615","kind":"news","pubTimestamp":1645008518,"share":"https://www.laohu8.com/m/news/1161161615?lang=&edition=full","pubTime":"2022-02-16 18:48","market":"us","language":"en","title":"Apple, Amazon, Microsoft or Tesla: Which Will Reach $5 Trillion First?","url":"https://stock-news.laohu8.com/highlight/detail?id=1161161615","media":"TheStreet","summary":"Apple crossed the $3 trillion market capitalization mark earlier this year, but when will it reach $5 trillion?","content":"<html><head></head><body><p>Apple crossed the $3 trillion market capitalization mark earlier this year, but when will it reach $5 trillion?</p><p>Next stop, $5 trillion.</p><p>Apple may no longer be a $3 trillion company after reaching that milestone earlier this year, but it is in lead to become the first company with a $5 trillion valuation.</p><p>A record high stock market has made possible market capitalizations that were once thought to be impossible.</p><p>Japan, the world's third biggest economy has a gross domestic product of $4.872 trillion, meaning a handful of American companies could one day be worth more that the entire output of economic powerhouses like Japan and Germany.</p><p>In this environment, Apple, which currently has a $2.82 billion valuation, isn't the only company within shooting distance of the $5 trillion mark.</p><p>A new research report by XTB.com predicts when the world's biggest companies might hit the milestone using historical market cap data and new research.</p><p><b>Standings In the Race to $5 Trillion</b></p><p>After beating everyone else to $3 trillion, Apple is also the leading candidate to get to $5 trillion, with an estimated year of 2028 for the company to cross that threshold.</p><p>Rival tech company Microsoft ($2.25 trillion) and Amazon ($1.59 trillion) are both projected to reach the mark in 2035.</p><p>Carmaker Tesla ($953.34 billion) and chipmaker Nvidia ($660 billion) are both estimated to reach $5 trillion in 2066.</p><p>Fellow semiconductor company Taiwan Semiconductor(<b>TSM</b>) ($645.76 billion) is scheduled to move next in 2078. It would be the first company based outside the U.S. to reach the goal.</p><p>Tencent Holdings ($596 billion) will become a $5 trillion company getting on the board in 2083, according XTB.com.</p><p>The study does not mention Alphabet, parent company of Google, whose valuation is currently close to $1.81 trillion.</p><p><b>Growth Prospects That Get You to $5 Trillion</b></p><p>It will take some serious work for Apple, already the world's most valuable company, to double its market cap over the next six years.</p><p>The most accessible growth opportunity for the company is already being produced by Apple, according to a recent Wells Fargo analyst note on the company.</p><p>\"While Apple's Mac revenue only accounts for about 10% of total revenue, we have seen Apple become increasingly vocal about the adoption of Macs in the enterprise space,\" analyst Aaron Rakers said.</p><p>\"When this productivity increase is scaled across a large enterprise/organization with hundreds of developers, the savings could justify upgrading entire fleets of Macs, perhaps sooner than dictated by the typical three-to-four-year upgrade cycle.\"</p><p>Meanwhile Microsoft is making big bets on gaming as a growth driver in the near-term.</p><p>Microsoft paid $75 billion, including debt, to buyvideo game studio Activision last month.</p><p>\"Gaming is the most dynamic and exciting category in entertainment across all platforms today and will play a key role in the development of metaverse platforms,” said Microsoft CEO Satya <a class=\"promotion-word\" href=\"https://laohu8.com/U/4197433649479962\">Nadella</a>.</p><p>Amazon has its fingers in everything. It's mainstay package delivery business continues to expand as the company saw its net income nearly double from last year to $14.3 billion.</p><p>But its Amazon Web Services business could be the biggest factor in getting the company to $5 trillion.</p><p>AWS saw its operating income rise 48.5% year over year to $5.3 billion.</p><p>Additionally, the company raised the price of its Prime delivery service to $14.99 from $12.99 per month with the new price slated to go into effect this week.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>Apple, Amazon, Microsoft or Tesla: Which Will Reach $5 Trillion First?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple, Amazon, Microsoft or Tesla: Which Will Reach $5 Trillion First?\n</h2>\n<h4 class=\"meta\">\n\n\n2022-02-16 18:48 GMT+8   <a href=\"https://www.thestreet.com/investing/apple-amazon-microsoft-or-tesla-which-will-reach-5-trillion-first\"><strong>TheStreet</strong></a>\n</h4>\n</header>\n<article>\n<div>\n<p>Apple crossed the $3 trillion market capitalization mark earlier this year, but when will it reach $5 trillion?Next stop, $5 trillion.Apple may no longer be a $3 trillion company after reaching that ...</p>\n<a href=\"https://www.thestreet.com/investing/apple-amazon-microsoft-or-tesla-which-will-reach-5-trillion-first\">Web Link</a>\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果","TSLA":"特斯拉","MSFT":"微软","AMZN":"亚马逊"},"source_url":"https://www.thestreet.com/investing/apple-amazon-microsoft-or-tesla-which-will-reach-5-trillion-first","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1161161615","content_text":"Apple crossed the $3 trillion market capitalization mark earlier this year, but when will it reach $5 trillion?Next stop, $5 trillion.Apple may no longer be a $3 trillion company after reaching that milestone earlier this year, but it is in lead to become the first company with a $5 trillion valuation.A record high stock market has made possible market capitalizations that were once thought to be impossible.Japan, the world's third biggest economy has a gross domestic product of $4.872 trillion, meaning a handful of American companies could one day be worth more that the entire output of economic powerhouses like Japan and Germany.In this environment, Apple, which currently has a $2.82 billion valuation, isn't the only company within shooting distance of the $5 trillion mark.A new research report by XTB.com predicts when the world's biggest companies might hit the milestone using historical market cap data and new research.Standings In the Race to $5 TrillionAfter beating everyone else to $3 trillion, Apple is also the leading candidate to get to $5 trillion, with an estimated year of 2028 for the company to cross that threshold.Rival tech company Microsoft ($2.25 trillion) and Amazon ($1.59 trillion) are both projected to reach the mark in 2035.Carmaker Tesla ($953.34 billion) and chipmaker Nvidia ($660 billion) are both estimated to reach $5 trillion in 2066.Fellow semiconductor company Taiwan Semiconductor(TSM) ($645.76 billion) is scheduled to move next in 2078. It would be the first company based outside the U.S. to reach the goal.Tencent Holdings ($596 billion) will become a $5 trillion company getting on the board in 2083, according XTB.com.The study does not mention Alphabet, parent company of Google, whose valuation is currently close to $1.81 trillion.Growth Prospects That Get You to $5 TrillionIt will take some serious work for Apple, already the world's most valuable company, to double its market cap over the next six years.The most accessible growth opportunity for the company is already being produced by Apple, according to a recent Wells Fargo analyst note on the company.\"While Apple's Mac revenue only accounts for about 10% of total revenue, we have seen Apple become increasingly vocal about the adoption of Macs in the enterprise space,\" analyst Aaron Rakers said.\"When this productivity increase is scaled across a large enterprise/organization with hundreds of developers, the savings could justify upgrading entire fleets of Macs, perhaps sooner than dictated by the typical three-to-four-year upgrade cycle.\"Meanwhile Microsoft is making big bets on gaming as a growth driver in the near-term.Microsoft paid $75 billion, including debt, to buyvideo game studio Activision last month.\"Gaming is the most dynamic and exciting category in entertainment across all platforms today and will play a key role in the development of metaverse platforms,” said Microsoft CEO Satya Nadella.Amazon has its fingers in everything. It's mainstay package delivery business continues to expand as the company saw its net income nearly double from last year to $14.3 billion.But its Amazon Web Services business could be the biggest factor in getting the company to $5 trillion.AWS saw its operating income rise 48.5% year over year to $5.3 billion.Additionally, the company raised the price of its Prime delivery service to $14.99 from $12.99 per month with the new price slated to go into effect this week.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1204,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":633479068,"gmtCreate":1644302008498,"gmtModify":1644302008806,"author":{"id":"4089812543711440","authorId":"4089812543711440","name":"Tiramisu2020","avatar":"https://static.tigerbbs.com/c7923aecbb67682b46eed9d583bc08c3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089812543711440","authorIdStr":"4089812543711440"},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/633479068","repostId":"1189839329","repostType":2,"isVote":1,"tweetType":1,"viewCount":456,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":633559539,"gmtCreate":1644237219227,"gmtModify":1644237219574,"author":{"id":"4089812543711440","authorId":"4089812543711440","name":"Tiramisu2020","avatar":"https://static.tigerbbs.com/c7923aecbb67682b46eed9d583bc08c3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089812543711440","authorIdStr":"4089812543711440"},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/633559539","repostId":"1167512836","repostType":2,"isVote":1,"tweetType":1,"viewCount":758,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":639769734,"gmtCreate":1643458550222,"gmtModify":1643458555552,"author":{"id":"4089812543711440","authorId":"4089812543711440","name":"Tiramisu2020","avatar":"https://static.tigerbbs.com/c7923aecbb67682b46eed9d583bc08c3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089812543711440","authorIdStr":"4089812543711440"},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/639769734","repostId":"1126017084","repostType":4,"repost":{"id":"1126017084","kind":"news","pubTimestamp":1643441538,"share":"https://www.laohu8.com/m/news/1126017084?lang=&edition=full","pubTime":"2022-01-29 15:32","market":"us","language":"en","title":"Why Mastercard Stock Blasted 9% Higher Today","url":"https://stock-news.laohu8.com/highlight/detail?id=1126017084","media":"Motley Fool","summary":"Mastercard exited 2021 in style, delivering a fourth quarter that handily beat estimates and demonst","content":"<html><head></head><body><p><a href=\"https://laohu8.com/S/MA\"><b>Mastercard</b></a> exited 2021 in style, delivering a fourth quarter that handily beat estimates and demonstrated that the company's business is continuing to grow robustly. After it posted those quarterly figures early on Thursday, several analysts upped their price targets on the stock the following day. These developments drew investors back to the payment card giant's shares, which closed over 9% higher.</p><p>So what</p><p>For the quarter, Mastercard's net revenue surged 27% higher year over year to $5.2 billion, whilenon-GAAP(adjusted) net income improved by 41% to $2.3 billion ($2.35 per share). On average, analysts had been forecasting $5.17 billion on the top line, with an adjusted per-share net profit of only $2.21.</p><p>Two of those analysts,<b>Morgan Stanley</b>'s James Faucette and BMO Capital's James Fotheringham, both raised their price targets on Mastercard stock in the wake of the earnings release.</p><p>Both did so incrementally, with Faucette adding $1 for a new target of $449 per share and Fotheringham lifting his by $2 to $401. Both analysts are also reiterating the equivalent of a buy recommendation on the stock.</p><p>In particular, Faucette is cheered by the resilience of consumer spending on travel, an important part of the company's business.</p><p>\"We found it encouraging that [Mastercard management] reiterated their expectation that cross-border travel can return to 2019's levels by year-end 2022, despite market concern that omicron and/or potential future variants may have pushed the outlook,\" the analyst wrote in a new research note.</p><p>Now what</p><p>While thetravel sectorhas been admirably resilient in the face of the coronavirus lately, it's set to really take off (no pun intended) when/if the threat recedes sharply. On top of that, the \"war on cash\" isn't over, and the best digital and card payment processors are on the winning side. Both trends were apparent in Mastercard's Q4, so its Friday share price pop was entirely justified.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>Why Mastercard Stock Blasted 9% Higher Today</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Mastercard Stock Blasted 9% Higher Today\n</h2>\n<h4 class=\"meta\">\n\n\n2022-01-29 15:32 GMT+8   <a href=\"https://www.fool.com/investing/2022/01/28/why-mastercard-stock-blasted-9-higher-today/\"><strong>Motley Fool</strong></a>\n</h4>\n</header>\n<article>\n<div>\n<p>Mastercard exited 2021 in style, delivering a fourth quarter that handily beat estimates and demonstrated that the company's business is continuing to grow robustly. After it posted those quarterly ...</p>\n<a href=\"https://www.fool.com/investing/2022/01/28/why-mastercard-stock-blasted-9-higher-today/\">Web Link</a>\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MA":"万事达"},"source_url":"https://www.fool.com/investing/2022/01/28/why-mastercard-stock-blasted-9-higher-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1126017084","content_text":"Mastercard exited 2021 in style, delivering a fourth quarter that handily beat estimates and demonstrated that the company's business is continuing to grow robustly. After it posted those quarterly figures early on Thursday, several analysts upped their price targets on the stock the following day. These developments drew investors back to the payment card giant's shares, which closed over 9% higher.So whatFor the quarter, Mastercard's net revenue surged 27% higher year over year to $5.2 billion, whilenon-GAAP(adjusted) net income improved by 41% to $2.3 billion ($2.35 per share). On average, analysts had been forecasting $5.17 billion on the top line, with an adjusted per-share net profit of only $2.21.Two of those analysts,Morgan Stanley's James Faucette and BMO Capital's James Fotheringham, both raised their price targets on Mastercard stock in the wake of the earnings release.Both did so incrementally, with Faucette adding $1 for a new target of $449 per share and Fotheringham lifting his by $2 to $401. Both analysts are also reiterating the equivalent of a buy recommendation on the stock.In particular, Faucette is cheered by the resilience of consumer spending on travel, an important part of the company's business.\"We found it encouraging that [Mastercard management] reiterated their expectation that cross-border travel can return to 2019's levels by year-end 2022, despite market concern that omicron and/or potential future variants may have pushed the outlook,\" the analyst wrote in a new research note.Now whatWhile thetravel sectorhas been admirably resilient in the face of the coronavirus lately, it's set to really take off (no pun intended) when/if the threat recedes sharply. On top of that, the \"war on cash\" isn't over, and the best digital and card payment processors are on the winning side. Both trends were apparent in Mastercard's Q4, so its Friday share price pop was entirely justified.","news_type":1},"isVote":1,"tweetType":1,"viewCount":435,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":630988327,"gmtCreate":1642664635167,"gmtModify":1642664635480,"author":{"id":"4089812543711440","authorId":"4089812543711440","name":"Tiramisu2020","avatar":"https://static.tigerbbs.com/c7923aecbb67682b46eed9d583bc08c3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089812543711440","authorIdStr":"4089812543711440"},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/630988327","repostId":"1178411704","repostType":4,"repost":{"id":"1178411704","kind":"news","pubTimestamp":1642649050,"share":"https://www.laohu8.com/m/news/1178411704?lang=&edition=full","pubTime":"2022-01-20 11:24","market":"us","language":"en","title":"Cathie Wood's Ark Trims Exposure In Netflix Ahead Of Earnings Report","url":"https://stock-news.laohu8.com/highlight/detail?id=1178411704","media":"Benzinga","summary":"Cathie Wood’s money managing firm Ark Investment Management on Wednesday further lowered its exposur","content":"<html><head></head><body><p>Cathie Wood’s money managing firm Ark Investment Management on Wednesday further lowered its exposure in the streaming video-on-demand company Netflix Inc NFLX +0.99% ahead of its quarterly earnings report.</p><p>Ark Invest sold 3,000 shares — estimated to be worth $1.5 million based on the latest closing price — in Netflix on Wednesday.</p><p>Netflix shares closed 0.9% higher at $515.8 a share on Wednesday. The stock is down 13.6% so far this year and is on pace to record its worst monthly performance since October 2018.</p><p>The St. Petersburg, Florida-based Ark Invest sold shares in the video streaming company via the Ark Space Exploration & Innovation ETF (BATS: ARKX). No other Ark Invest ETF currently owns shares in Netflix.</p><p>ARKX held 13,332 shares — worth $6.8 million — in Netflix, prior to Wednesday’s trade.</p><p>Ark Invest had in July trimmed its stake in the video-on-demand company just days after spelling out a bull’s case on the stock. At the time, it said that Netflix would see a “meaningful increment” in revenue if it managed to grab a “fraction” of the highly-competitive video-gaming market.</p><p>Netflix is scheduled to announce its quarterly financial results after the market closes on Thursday.</p><p>BofA Securities analyst Nat Schindler has maintained a Buy rating on Netflix with a price target of $750.</p><p>Here are a few other key Ark Invest trades on Wednesday:</p><p>Sold 584,565 shares — estimated to be worth $3.2 million — in Skillz Inc SKLZ -2.1% on the dip. Shares of the company closed 1.9% lower at $5.5 a share on Wednesday.</p></body></html>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>Cathie Wood's Ark Trims Exposure In Netflix Ahead Of Earnings Report</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCathie Wood's Ark Trims Exposure In Netflix Ahead Of Earnings Report\n</h2>\n<h4 class=\"meta\">\n\n\n2022-01-20 11:24 GMT+8   <a href=\"https://www.benzinga.com/news/22/01/25125646/cathie-woods-ark-trims-exposure-in-netflix-ahead-of-earnings-report\"><strong>Benzinga</strong></a>\n</h4>\n</header>\n<article>\n<div>\n<p>Cathie Wood’s money managing firm Ark Investment Management on Wednesday further lowered its exposure in the streaming video-on-demand company Netflix Inc NFLX +0.99% ahead of its quarterly earnings ...</p>\n<a href=\"https://www.benzinga.com/news/22/01/25125646/cathie-woods-ark-trims-exposure-in-netflix-ahead-of-earnings-report\">Web Link</a>\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NFLX":"奈飞","ARKX":"ARK Space Exploration & Innovation ETF","ARKK":"ARK Innovation ETF"},"source_url":"https://www.benzinga.com/news/22/01/25125646/cathie-woods-ark-trims-exposure-in-netflix-ahead-of-earnings-report","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1178411704","content_text":"Cathie Wood’s money managing firm Ark Investment Management on Wednesday further lowered its exposure in the streaming video-on-demand company Netflix Inc NFLX +0.99% ahead of its quarterly earnings report.Ark Invest sold 3,000 shares — estimated to be worth $1.5 million based on the latest closing price — in Netflix on Wednesday.Netflix shares closed 0.9% higher at $515.8 a share on Wednesday. The stock is down 13.6% so far this year and is on pace to record its worst monthly performance since October 2018.The St. Petersburg, Florida-based Ark Invest sold shares in the video streaming company via the Ark Space Exploration & Innovation ETF (BATS: ARKX). No other Ark Invest ETF currently owns shares in Netflix.ARKX held 13,332 shares — worth $6.8 million — in Netflix, prior to Wednesday’s trade.Ark Invest had in July trimmed its stake in the video-on-demand company just days after spelling out a bull’s case on the stock. At the time, it said that Netflix would see a “meaningful increment” in revenue if it managed to grab a “fraction” of the highly-competitive video-gaming market.Netflix is scheduled to announce its quarterly financial results after the market closes on Thursday.BofA Securities analyst Nat Schindler has maintained a Buy rating on Netflix with a price target of $750.Here are a few other key Ark Invest trades on Wednesday:Sold 584,565 shares — estimated to be worth $3.2 million — in Skillz Inc SKLZ -2.1% on the dip. Shares of the company closed 1.9% lower at $5.5 a share on Wednesday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":335,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":697784387,"gmtCreate":1642594590712,"gmtModify":1642594591764,"author":{"id":"4089812543711440","authorId":"4089812543711440","name":"Tiramisu2020","avatar":"https://static.tigerbbs.com/c7923aecbb67682b46eed9d583bc08c3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089812543711440","authorIdStr":"4089812543711440"},"themes":[],"htmlText":"cool","listText":"cool","text":"cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/697784387","repostId":"1142919906","repostType":4,"repost":{"id":"1142919906","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1642575947,"share":"https://www.laohu8.com/m/news/1142919906?lang=&edition=full","pubTime":"2022-01-19 15:05","market":"us","language":"en","title":"Tesla Q4 Earnings Are Coming - What To Expect","url":"https://stock-news.laohu8.com/highlight/detail?id=1142919906","media":"Tiger Newspress","summary":"Tesla announced that it will release its Q4, 2021 earnings report after the closing bell on Wednesda","content":"<html><head></head><body><p>Tesla announced that it will release its Q4, 2021 earnings report after the closing bell on Wednesday, January 26, and <a class=\"promotion-word\" href=\"https://laohu8.com/U/4197425891462882\">Elon Musk</a> confirmed that he will come back to the call and give a Tesla product roadmap update.</p><p><b>Product roadmap update</b></p><p>Last year, CEO <a class=\"promotion-word\" href=\"https://laohu8.com/U/4197425891462882\">Elon Musk</a> announced that he wouldn’t attend the earnings conference call anymore.</p><p>However, <a class=\"promotion-word\" href=\"https://laohu8.com/U/4197425891462882\">Musk</a> said last month that he would be attending the next call to give a “product roadmap update”:</p><p>Tesla still has a few products customers are eager to know more about, particularly the Cybertruck and Semi.</p><p>For example, PepsiCo is expected to receive its first batch of Tesla Semi deliveries at the end of this month. <a class=\"promotion-word\" href=\"https://laohu8.com/U/4197425891462882\">Musk</a> might provide a more solid timeframe for Semi deliveries and Tesla’s progress on Class 8 truck’s production at the upcoming earnings call.</p><p>As for the Cybertruck, Tesla had previously stated that it already produced a few alpha prototypes of the all-electric pickup. A few people have already spotted the Cybertruck alpha prototypes in the wild a few times.</p><p>A Tesla product roadmap would provide details on the company’s plans moving forward. 2022 is likely to be a big year for Tesla, especially considering its plans to produce vehicles at Giga Texas and Giga Berlin. Giga Shanghai also plans to increase production capacity with an RMB 1.2B ($188 million) expansion project.</p><p><b>Fourth-quarter results are critical</b></p><p>Tesla's fourth-quarter results are critical to validate the third-quarter dynamics that could see the company carving out meaningful share from legacy automakers and claim a disproportionate share of the industry profit pool, Jefferies analyst Philippe Houchois said in a note.</p><p>Annualizing fourth-quarter production suggests active capacity of 1.3 million units, the analyst said. Adding 50,000 units for the underused Model S/X vehicles and 600,000-unit capacity for Austin and Berlin, total capacity for the year end is close to 2 million units, he said.</p><p>Annualized production of 710,000 at Giga Shanghai shows the facility is breaking out of automotive production norms toward <a class=\"promotion-word\" href=\"https://laohu8.com/U/4197425891462882\">Elon Musk</a>'s ambition that each site should produce 1 million units. Reaching that number, Houchois said, is not a given due to general capacity constraints.</p><p>Citing acceleration in BEV demand and a growing backlog of vehicle orders, the analyst raised his 2022 sales forecast up by 12% to 1.51 million units. This is based on the assumption that the Austin and Berlin factories will start producing deliverable Model Ys in February and April, respectively.</p><p><b>Tesla gets an upbeat call ahead of earnings</b></p><p>Credit Suisse analyst Dan Levy raised his target price for the shares ahead of the company’s fourth-quarter earnings report.</p><p>Levy increased his target price to $1,025 from $830 a share, saying he expects earnings to be stronger than Wall Street has penciled in, but kept his rating on the shares at the equivalent of Hold.</p><p>Levy projects Tesla will earn $2.81 a share for the fourth quarter of 2021, while Wall Street is looking for just $2.25.</p><p>Beyond earnings, Levy sees four keys to the performance of Tesla shares: How fast the company increases production capacity, the direction of gross profit margins, the introduction of new batteries, and product announcements.</p><p>Tesla is starting up two production facilities in coming weeks, one in Austin, Texas, and the other near Berlin, Germany. That will essentially double Tesla’s production capacity.</p><p>“With Tesla’s demand exceeding supply likely for the foreseeable future, Tesla’s path of volume will be purely a function of its production,” wrote Levy in his report. He projects almost 1.5 million deliveries in 2022, up from about 936,000 in 2021. Levy also expects the existing plant in Shanghai to boost its production this year.</p><p>The start of the new plants could weigh on margins because it takes a while for a huge new facility to begin operating at capacity, but Levy still expects better gross profit margins in 2022. He believes higher vehicle prices can offset any drag from inflation or start-up costs.</p><p>Tesla is also expected to debut new, larger batteries, offering better performance and longer life, in 2022. The 4680 cells have a diameter of 46 millimeters and height of 80 millimeters, while the current batteries are 21 millimeters in diameter and 70 millimeters high. Tesla is also redesigning the battery pack for its new batteries, a move that is intended to reduce production costs.</p><p>The company has also said a $25,000 EV is in the cards, a product that would open up more of the car market to Tesla, given that a Tesla Model 3 starts at about $45,000 today. Levy thinks that the announcement could come this year.</p><p>The reason Levy is sticking with a Hold rating on Tesla despite all those positive factors is the stock’s lofty valuation. The stock trades at 108 times the per-share earnings expected for 2022, according to FactSet, compared with 32 times for the Russell 1000 Growth index.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>Tesla Q4 Earnings Are Coming - What To Expect</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla Q4 Earnings Are Coming - What To Expect\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-01-19 15:05</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Tesla announced that it will release its Q4, 2021 earnings report after the closing bell on Wednesday, January 26, and <a class=\"promotion-word\" href=\"https://laohu8.com/U/4197425891462882\">Elon Musk</a> confirmed that he will come back to the call and give a Tesla product roadmap update.</p><p><b>Product roadmap update</b></p><p>Last year, CEO <a class=\"promotion-word\" href=\"https://laohu8.com/U/4197425891462882\">Elon Musk</a> announced that he wouldn’t attend the earnings conference call anymore.</p><p>However, <a class=\"promotion-word\" href=\"https://laohu8.com/U/4197425891462882\">Musk</a> said last month that he would be attending the next call to give a “product roadmap update”:</p><p>Tesla still has a few products customers are eager to know more about, particularly the Cybertruck and Semi.</p><p>For example, PepsiCo is expected to receive its first batch of Tesla Semi deliveries at the end of this month. <a class=\"promotion-word\" href=\"https://laohu8.com/U/4197425891462882\">Musk</a> might provide a more solid timeframe for Semi deliveries and Tesla’s progress on Class 8 truck’s production at the upcoming earnings call.</p><p>As for the Cybertruck, Tesla had previously stated that it already produced a few alpha prototypes of the all-electric pickup. A few people have already spotted the Cybertruck alpha prototypes in the wild a few times.</p><p>A Tesla product roadmap would provide details on the company’s plans moving forward. 2022 is likely to be a big year for Tesla, especially considering its plans to produce vehicles at Giga Texas and Giga Berlin. Giga Shanghai also plans to increase production capacity with an RMB 1.2B ($188 million) expansion project.</p><p><b>Fourth-quarter results are critical</b></p><p>Tesla's fourth-quarter results are critical to validate the third-quarter dynamics that could see the company carving out meaningful share from legacy automakers and claim a disproportionate share of the industry profit pool, Jefferies analyst Philippe Houchois said in a note.</p><p>Annualizing fourth-quarter production suggests active capacity of 1.3 million units, the analyst said. Adding 50,000 units for the underused Model S/X vehicles and 600,000-unit capacity for Austin and Berlin, total capacity for the year end is close to 2 million units, he said.</p><p>Annualized production of 710,000 at Giga Shanghai shows the facility is breaking out of automotive production norms toward <a class=\"promotion-word\" href=\"https://laohu8.com/U/4197425891462882\">Elon Musk</a>'s ambition that each site should produce 1 million units. Reaching that number, Houchois said, is not a given due to general capacity constraints.</p><p>Citing acceleration in BEV demand and a growing backlog of vehicle orders, the analyst raised his 2022 sales forecast up by 12% to 1.51 million units. This is based on the assumption that the Austin and Berlin factories will start producing deliverable Model Ys in February and April, respectively.</p><p><b>Tesla gets an upbeat call ahead of earnings</b></p><p>Credit Suisse analyst Dan Levy raised his target price for the shares ahead of the company’s fourth-quarter earnings report.</p><p>Levy increased his target price to $1,025 from $830 a share, saying he expects earnings to be stronger than Wall Street has penciled in, but kept his rating on the shares at the equivalent of Hold.</p><p>Levy projects Tesla will earn $2.81 a share for the fourth quarter of 2021, while Wall Street is looking for just $2.25.</p><p>Beyond earnings, Levy sees four keys to the performance of Tesla shares: How fast the company increases production capacity, the direction of gross profit margins, the introduction of new batteries, and product announcements.</p><p>Tesla is starting up two production facilities in coming weeks, one in Austin, Texas, and the other near Berlin, Germany. That will essentially double Tesla’s production capacity.</p><p>“With Tesla’s demand exceeding supply likely for the foreseeable future, Tesla’s path of volume will be purely a function of its production,” wrote Levy in his report. He projects almost 1.5 million deliveries in 2022, up from about 936,000 in 2021. Levy also expects the existing plant in Shanghai to boost its production this year.</p><p>The start of the new plants could weigh on margins because it takes a while for a huge new facility to begin operating at capacity, but Levy still expects better gross profit margins in 2022. He believes higher vehicle prices can offset any drag from inflation or start-up costs.</p><p>Tesla is also expected to debut new, larger batteries, offering better performance and longer life, in 2022. The 4680 cells have a diameter of 46 millimeters and height of 80 millimeters, while the current batteries are 21 millimeters in diameter and 70 millimeters high. Tesla is also redesigning the battery pack for its new batteries, a move that is intended to reduce production costs.</p><p>The company has also said a $25,000 EV is in the cards, a product that would open up more of the car market to Tesla, given that a Tesla Model 3 starts at about $45,000 today. Levy thinks that the announcement could come this year.</p><p>The reason Levy is sticking with a Hold rating on Tesla despite all those positive factors is the stock’s lofty valuation. The stock trades at 108 times the per-share earnings expected for 2022, according to FactSet, compared with 32 times for the Russell 1000 Growth index.</p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1142919906","content_text":"Tesla announced that it will release its Q4, 2021 earnings report after the closing bell on Wednesday, January 26, and Elon Musk confirmed that he will come back to the call and give a Tesla product roadmap update.Product roadmap updateLast year, CEO Elon Musk announced that he wouldn’t attend the earnings conference call anymore.However, Musk said last month that he would be attending the next call to give a “product roadmap update”:Tesla still has a few products customers are eager to know more about, particularly the Cybertruck and Semi.For example, PepsiCo is expected to receive its first batch of Tesla Semi deliveries at the end of this month. Musk might provide a more solid timeframe for Semi deliveries and Tesla’s progress on Class 8 truck’s production at the upcoming earnings call.As for the Cybertruck, Tesla had previously stated that it already produced a few alpha prototypes of the all-electric pickup. A few people have already spotted the Cybertruck alpha prototypes in the wild a few times.A Tesla product roadmap would provide details on the company’s plans moving forward. 2022 is likely to be a big year for Tesla, especially considering its plans to produce vehicles at Giga Texas and Giga Berlin. Giga Shanghai also plans to increase production capacity with an RMB 1.2B ($188 million) expansion project.Fourth-quarter results are criticalTesla's fourth-quarter results are critical to validate the third-quarter dynamics that could see the company carving out meaningful share from legacy automakers and claim a disproportionate share of the industry profit pool, Jefferies analyst Philippe Houchois said in a note.Annualizing fourth-quarter production suggests active capacity of 1.3 million units, the analyst said. Adding 50,000 units for the underused Model S/X vehicles and 600,000-unit capacity for Austin and Berlin, total capacity for the year end is close to 2 million units, he said.Annualized production of 710,000 at Giga Shanghai shows the facility is breaking out of automotive production norms toward Elon Musk's ambition that each site should produce 1 million units. Reaching that number, Houchois said, is not a given due to general capacity constraints.Citing acceleration in BEV demand and a growing backlog of vehicle orders, the analyst raised his 2022 sales forecast up by 12% to 1.51 million units. This is based on the assumption that the Austin and Berlin factories will start producing deliverable Model Ys in February and April, respectively.Tesla gets an upbeat call ahead of earningsCredit Suisse analyst Dan Levy raised his target price for the shares ahead of the company’s fourth-quarter earnings report.Levy increased his target price to $1,025 from $830 a share, saying he expects earnings to be stronger than Wall Street has penciled in, but kept his rating on the shares at the equivalent of Hold.Levy projects Tesla will earn $2.81 a share for the fourth quarter of 2021, while Wall Street is looking for just $2.25.Beyond earnings, Levy sees four keys to the performance of Tesla shares: How fast the company increases production capacity, the direction of gross profit margins, the introduction of new batteries, and product announcements.Tesla is starting up two production facilities in coming weeks, one in Austin, Texas, and the other near Berlin, Germany. That will essentially double Tesla’s production capacity.“With Tesla’s demand exceeding supply likely for the foreseeable future, Tesla’s path of volume will be purely a function of its production,” wrote Levy in his report. He projects almost 1.5 million deliveries in 2022, up from about 936,000 in 2021. Levy also expects the existing plant in Shanghai to boost its production this year.The start of the new plants could weigh on margins because it takes a while for a huge new facility to begin operating at capacity, but Levy still expects better gross profit margins in 2022. He believes higher vehicle prices can offset any drag from inflation or start-up costs.Tesla is also expected to debut new, larger batteries, offering better performance and longer life, in 2022. The 4680 cells have a diameter of 46 millimeters and height of 80 millimeters, while the current batteries are 21 millimeters in diameter and 70 millimeters high. Tesla is also redesigning the battery pack for its new batteries, a move that is intended to reduce production costs.The company has also said a $25,000 EV is in the cards, a product that would open up more of the car market to Tesla, given that a Tesla Model 3 starts at about $45,000 today. Levy thinks that the announcement could come this year.The reason Levy is sticking with a Hold rating on Tesla despite all those positive factors is the stock’s lofty valuation. The stock trades at 108 times the per-share earnings expected for 2022, according to FactSet, compared with 32 times for the Russell 1000 Growth index.","news_type":1},"isVote":1,"tweetType":1,"viewCount":342,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":697875648,"gmtCreate":1642422471824,"gmtModify":1642422472100,"author":{"id":"4089812543711440","authorId":"4089812543711440","name":"Tiramisu2020","avatar":"https://static.tigerbbs.com/c7923aecbb67682b46eed9d583bc08c3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089812543711440","authorIdStr":"4089812543711440"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/697875648","repostId":"1131862461","repostType":4,"repost":{"id":"1131862461","kind":"news","pubTimestamp":1642412568,"share":"https://www.laohu8.com/m/news/1131862461?lang=&edition=full","pubTime":"2022-01-17 17:42","market":"us","language":"en","title":"Moderna: High Upside Potential At Current Prices","url":"https://stock-news.laohu8.com/highlight/detail?id=1131862461","media":"Seeking Alpha","summary":"SummaryModerna has a significant first mover competitive advantage by not only developing the COVID-","content":"<html><head></head><body><p><b>Summary</b></p><ul><li>Moderna has a significant first mover competitive advantage by not only developing the COVID-19 vaccine but also by scaling the company's mRNA manufacturing capacity.</li><li>Moderna recently reported the preliminary COVID-19 estimate for product sales in 2021 as being approximately $17.5 billion.</li><li>Recently, Singapore released data showing that COVID-19 deaths were the lowest among Moderna vaccine takers.</li><li>One of the ways that Moderna is keeping ahead of potential mRNA competition is using its $15.3 billion in cash and $3.2 billion in Free Cash Flow to continue building out significant mRNA manufacturing capability across the world.</li><li>The 58% pullback from Moderna's all-time high of $497.49 gives aggressive growth investors a chance to buy into a company with significant upside potential.</li></ul><p class=\"t-img-caption\"><img height=\"auto\" src=\"https://static.tigerbbs.com/466434ab0d3291095a83741482c15948\" tg-height=\"1024\" tg-width=\"1536\" width=\"100%\"/><span>Maddie Meyer/Getty Images News</span></p><p>Moderna (NASDAQ:MRNA) has extremely high upside from being a first mover in developing the world's most advanced mRNA platform. One of the most promising potential solutions for helping prevent or cure some of the most intractable diseases known to man is mRNA technology and Moderna has not only developed the most advanced mRNA platform but has also built out significant mRNA manufacturing capacity worldwide. There are many companies that are in various stages of developing mRNA technology but there are very few that have advanced as far as Moderna has in both developing mRNA technology, as well as having the manufacturing capacity and other commercial infrastructure to produce billions of doses of a vaccine per year. At this time, the only companies that have both the knowledge of advanced mRNA techniques and the manufacturing capacity to compete in the same arena as Moderna is the BioNTech (NASDAQ:BNTX) - Pfizer (NYSE:PFE) partnership.</p><p>Moderna has a significant first mover competitive advantage by not only developing the COVID-19 vaccine but also by scaling the company's mRNA manufacturing capacity. It is one thing to produce mRNA in a lab setting but quite another to safely mass produce effective vaccines in regulator approved manufacturing sites around the world. Moderna's first mover advantage has translated into a very large war chest of cash from COVID-19 sales in which the company can use to further its lead by investing in advancing mRNA technology, improving mRNA manufacturing processes, and building out significant manufacturing capability worldwide. Moderna is also well along in developing one of the deepest drug pipelines in the world.</p><p>While a first mover advantage is not exactly a moat, for the next several years at least, Moderna should enjoy a significant lead in developing many different mRNA-based therapies or vaccines to treat numerous difficult to treat diseases. Moderna currently has 40 different drug development programs, which is almost unheard of for such a relatively young biotech company that only two years ago was simply a research outfit. In the end, Moderna's mRNA platform and manufacturing capacity should result in significant long-term upside for investors buying into Moderna's stock today.</p><p>Advantages of mRNA Technology</p><p>The reason why Moderna was able to rapidly develop a COVID-19 solution, while at the same time continuing to build out a significant number of drug development programs is because of the nature of mRNA technology.</p><blockquote>The development and manufacturing of mRNA for use as therapeutics<i>and</i>vaccines are comparatively simple, scalable<i>and</i>extremely rapid.</blockquote><blockquote>Source:Millapore Sigma</blockquote><p>There are numerous advantages of a mRNA platform over traditional drug making. The major advantages of a mRNA platform that were demonstrated by the response to the COVID-19 pandemic was the ability to take the sequence of the virus and quickly move from development, to clinical trials, to approval, to mass manufacturing of a vaccine in a very rapid period of time. As Moderna and others get more experience and regulatory bodies get more comfortable with mRNA technology, I can see the day in the future where the response time of discovery of a virulent virus to clinical trials of a vaccine, to vaccine approval, to mass manufacturing of the vaccine could significantly shrink. Right now, it looks like it takes about 9 months to a year to move from virus discovery to eventually making it into people's arms. Eventually, this response time could shrink to matter of a few months.</p><p>Omnicron was first identified as a variant around November 24, 2021. Moderna CEO Stéphane Bancel said in a CNBC interview that clinical trials for an Omnicron vaccine will start soon and a Omnicron vaccine should be available by fall. This type of rapid response to infectious diseases is unheard of before now and as time goes along, mRNA platform companies could not only become proficient in rapidly producing vaccines against specific viruses but also become proficient at producing vaccines against specific strains of a virus, in specific regions of the world. Among the reason why I think Moderna is building manufacturing capacity in different countries and regions of the world is because vaccines will eventually be less of a one size fits all countries and be more along the lines of regional manufacturing sites creating vaccines specific for the most prevalent viruses and strains of virus in that specific region.</p><p>Another potential huge advantage of a mRNA platform is flexibility. Theoretically, a mRNA manufacturing plant can be relatively rapidly switched to producing any other mRNA-based drug. It is possible that a mRNA plant that makes COVID-19 vaccines could be rapidly switched to making an Ebola vaccine, for instance. This is in contrast to the manufacturing process of many traditional drugs that require a dedicated plant to produce a drug. This could make the CapEx involved for producing multiple different types of drugs, far lower than a traditional drug manufacturer.</p><p>The COVID-19 pandemic has highlighted exactly how easy it is to change the vaccine simply by plugging the genetic sequence of any virus that Moderna wants to target right into its basic mRNA platform. This is not only useful for being able to attack different strains of COVID-19 but also means that Moderna has the ability of using the sequence of any virus whether that be the flu, HIV, CMV, Tuberculosis, Zika, or Rabies and quickly produce a vaccine ready for testing.</p><p><b>COVID-19 Progress</b></p><p>COVID-19 has totally changed the fortunes of Moderna within just two years. Up until 2020, Moderna was only a little-known drug research outfit that had very little revenues but being the second company to bring a viable vaccine to protect against COVID-19 into US markets, has made Moderna very widely known worldwide and the company has built a huge brand that is on the verge of becoming a giant within the drug industry.</p><p>There is real world evidence that up until now, Moderna has produced the most effective COVID-19 vaccine. Data from all over the world supports the very strong efficacy that was shown in phase III data in the USA. Recently, Singapore released data showing that COVID-19 deaths were lowest among Moderna takers. Singapore had 802 deaths out of which 70% were unvaccinated. Between Moderna, Pfizer-BioNTech, Sinopharm and Sinovac vaccines, Moderna had the least death rates:</p><ul><li>11 deaths per 100,000: Sinovac</li><li>7.8 deaths per 100,000: Sinopharm</li><li>6.2 deaths per 100,000: Pfizer/BioNTech</li><li>1 death per 100,000: Moderna</li></ul><p>Over the course of 2021, Moderna shipped 807 million doses of Spikevax, Moderna's COVID-19 vaccine, to many different locations around the world, with around 25% of those doses going to low-income and middle-income countries. Moderna reported recently during the JPMorgan 40th Annual Healthcare Conference on January 10th, that the preliminary estimate for Spikevax product sales in 2021 is around $17.5 billion.</p><p>Because of the huge demand for Moderna's vaccine worldwide, for a decent part of 2021, the company was supply constrained but that situation is beginning to turn around now. Moderna CEO Stephane Bancel attributes the reason for supply constraints as Moderna having a higher dose than the Pfizer-BioNTech vaccine. The higher dose was a big drain on manufacturing resources. Moderna has since built out additional manufacturing capacity over the course of 2021 and is now in much better shape to address COVID-19 demand. In Q4, Moderna shipped 300 million doses, which is a run rate of 1.2 billion doses. Moderna believes that they can produce two billion to three billion doses of boosters over the course of 2022, if necessary.</p><p class=\"t-img-caption\"><img height=\"auto\" src=\"https://static.tigerbbs.com/f41315e4b985027121aaf2dfca75dc71\" tg-height=\"356\" tg-width=\"640\" width=\"100%\"/><span>Moderna Spikevax advanced purchase agreements</span></p><p>Because COVID-19 vaccine makers have lately been having to play whack-a-mole with new variants, the demand for Spikevax is still rising. As can be seen from the above graphic, from November 4th to January 10th, Moderna has gained and additional $1.5 billion in advanced purchase agreements (\"APA\") and $0.5 Billion in options, with those numbers being mostly heavily weighted toward the first half of the year. Moderna is still having ongoing discussions with many countries about whether additional vaccines will need to be added to address the fall moving into winter of '22. I expect that when all is said and done, Moderna could wind up signing additional APAs over the course of the year. So, it looks like 2022 might again be another banner year for Moderna.</p><p class=\"t-img-caption\"><img height=\"auto\" src=\"https://static.tigerbbs.com/e1246421e026d6fd58bec48546a19260\" tg-height=\"362\" tg-width=\"640\" width=\"100%\"/><span>How COVID-19 is likely to evolve</span></p><p>Currently, the world is in the midst of variant reinfection waves, which will likely continue throughout 2022 but by 2023 COVID-19 should become more seasonal and endemic. Morbidity waves are expected to become lower and lower over the next several years and there is a good chance that COVID-19 will be seen more like the flu is perceived today within a year or two. Post-pandemic, COVID-19 is expected to mostly only affect people aged 50-plus, health care workers, immunocompromised people and other high-risk populations. These groups will likely need boosters to ensure that they do not get severe disease and hospitalization. As COVID-19 winds down, demand for Spikevax will probably begin dropping in the 2023-to-2024-time frame. This is why some people have been predicting revenue declines for Moderna. Well, what is Moderna's post pandemic plan to replace the likely COVID-19 vaccine declining revenues?</p><p><b>Moderna's Plan Moving Forward</b></p><p class=\"t-img-caption\"><img height=\"auto\" src=\"https://static.tigerbbs.com/a9965c1224ac3e57e5a4c764bbb50975\" tg-height=\"360\" tg-width=\"640\" width=\"100%\"/><span>Moderna Product Strategy in 2022</span></p><p>The initial way that Moderna plans on countering the likely COVID-19 vaccine decline is by bundling different seasonal respiratory vaccines together into just one vaccine. The days of getting COVID-19 specific vaccine seem to be waning and a pan-respiratory vaccine will likely compete extremely effectively with any laggards coming to the market late with only a COVID-19 solution.</p><p class=\"t-img-caption\"><img height=\"auto\" src=\"https://static.tigerbbs.com/4995949c9a253ebe6663e2deeb5ccce3\" tg-height=\"360\" tg-width=\"640\" width=\"100%\"/><span>Moderna vision for pan-respiratory vaccine</span></p><p>Moderna's vision is that an annual single-dose pan-respiratory booster can be customized to fit different demographics, different geographies, and different respiratory diseases over time. Eventually, Moderna even expects to target specific strains of respiratory diseases in specific regions. I wouldn't be surprised if a pan-respiratory vaccine starts to appear within two years.</p><p class=\"t-img-caption\"><img height=\"auto\" src=\"https://static.tigerbbs.com/eb027ec45a0750fdcd8b65307c4008d1\" tg-height=\"359\" tg-width=\"640\" width=\"100%\"/><span>Moderna Strategy After COVID-19</span></p><p>Unlike vaccine technology from companies like Novavax (NASDAQ:NVAX), mRNA can be used for many other different purposes besides infectious diseases.Novavax's pipeline only consists of 9 programs that target 5 other infectious diseases other than COVID-19. Most of Novavax's pipeline is mostly concerned with respiratory diseases, with only one direct contact latent virus, Ebola, appearing on the list.</p><p>In contrast, Moderna is much further ahead in developing solutions against multiple latent viruses that are a lot more prevalent than Ebola. The first ones being targeted and are already in clinical trials are CMV and EBV, with HIV soon to begin trials. CMV is Moderna's most advanced drug in the pipeline and the first patient has already been dosed in phase III trials. Besides CMV, EBV, and HIV, there a many other undisclosed latent viruses being worked on in the labs.</p><p>The next area that Moderna is prioritizing is in developing therapeutics using mRNA technology which allows the company to produce oncology products, cardio products, rare genetic disease products and autoimmune disease products. This is an area that has significant upside for Moderna. Moderna will be using totally new approaches to develop solutions against cancer and develop solutions for diseases that currently have no significant solutions. Recently, Moderna formed a partnership with Carisma Therapeutics. Moderna plans to combine its mRNA technology with Carisma Therapeutics' engineered macrophage technology to develop solutions against solid tumor cancer. The reason why this is important is because while autologous CAR-Ts have really good data in Heme malignancies, which are blood cancers, they have not been very effective in solid tumors and eighty percent of cancer patients die of solid tumors. I won't go deep into the science behind it but scientist know the reasons why CAR-Ts are not as effective with solid tumors, and both companies think Carisma Therapeutics' CAR-Macrophage's technology combined with mRNA technology can produce revolutionary new ways to essentially cure the most prevalent and difficult to treat form of cancer deaths which are solid tumors.</p><blockquote>Moderna's deep expertise in mRNA and LNP technologies opens up a potentially game-changing opportunity for engineered macrophages. In vivo delivery directly to monocytes and macrophages enables an off-the-shelf therapeutic approach that uses the patients' own cells to provide a truly personalized treatment.</blockquote><blockquote>Source: Steven Kelly, President and Chief Executive Officer of Carisma</blockquote><p>Right now, there is no way to factor in the upside of Moderna potentially developing a significantly better solution to attacking and possibly curing solid tumor cancer. The therapies that could come out of partnerships like the one Moderna has with Carisma could potentially produce home runs just as big, if not bigger than the COVID-19 vaccine.</p><p>The fourth area that Moderna is developing solutions using gene-editing enzymes. Moderna has only seriously got into gene editing relatively recently when the company signed a collaboration with Metagenomi. For those unaware,gene-editing is the same strategy that companies like Editas (NASDAQ:EDIT) and CRISPR Therapeutics (NASDAQ:CRSP) are pursuing. The focus for the Metagenomi collaboration will be on serious genetic diseases.</p><p class=\"t-img-caption\"><img height=\"auto\" src=\"https://static.tigerbbs.com/8041f6f8edad22795cbe4a3295d68973\" tg-height=\"361\" tg-width=\"640\" width=\"100%\"/><span>Moderna capital allocation priorities</span></p><p>Moderna has already started spending its huge cash flows derived from COVID-19 vaccine sales. I just wanted to include the above slide in this article because it shows that Moderna's number one capital allocation priority is investing in R&D, manufacturing infrastructure and continuing to build out the company's commercial infrastructure. The second priority is investing in external investment opportunities, either in the form of collaborations or M&A. The collaborations with Metagenomi and Carisma Therapeutics are examples of this second priority.</p><p><b>Manufacturing Capacity</b></p><p class=\"t-img-caption\"><img height=\"auto\" src=\"https://static.tigerbbs.com/36484ebc09cffbacbfa8ce06eea49f22\" tg-height=\"357\" tg-width=\"640\" width=\"100%\"/><span>Moderna In-country vaccine manufacturing</span></p><p>There is a rather large set of existing potential competitors to Moderna and there are also countries like India that are supporting rising home-grown mRNA platform companies. One of the ways that Moderna is keeping ahead of such efforts from competitors is using its $15.3 billion in cash and $3.2 billion in Free Cash Flow at the end of Q3, to build out significant mRNA manufacturing capability across the world. Moderna has announced in principle agreements with Australia and Canadato build out mRNA vaccine manufacturing plants within those countries. These announcements are in addition to the plans to build a factory capable of producing up to 500 million vaccine doses in Africa each year. I believe Moderna is still in the process of choosing which African country the manufacturing site will be located in.</p><p><b>Risks</b></p><p>The major risk that Moderna faces in the short term is revenue from the COVID-19 declining faster than Moderna can get other vaccines or therapies on to market and show superior results. The closest drug to approval is a CMV vaccine. An approval of the CMV vaccine would likely shoot Moderna's stock higher because it would show that mRNA is viable for addressing other diseases. A CMV rejection would likely drop Moderna's stock much lower.</p><p>Another major risk for Moderna are patent disputes and lawsuits. Moderna recently had to back down in a dispute with the NIH over COVID-19 patents and Moderna could also soon face a patent infringement lawsuit from Arbutus (NASDAQ:ABUS) over the COVID-19 vaccine. Currently, it is unknown how these disputes will impact Moderna over the longer term.</p><p><b>Analyst Price Targets</b></p><p class=\"t-img-caption\"><img height=\"auto\" src=\"https://static.tigerbbs.com/0c0e5d79d00e415b16e4141b35eaaad4\" tg-height=\"416\" tg-width=\"461\" width=\"100%\"/><span>Moderna Analyst Price Targets</span></p><p>The above is based on 15 Wall Street analysts offering 12-month price targets for Moderna in the last 3 months. The average price target is $289.07 with a high forecast of $506.00 and a low forecast of $86.00. The average price target represents a 38% increase from the last price of $210.17.</p><p><b>Valuation</b></p><p class=\"t-img-caption\"><img height=\"auto\" src=\"https://static.tigerbbs.com/19ae061dd4c060bb37f43ff041dc2577\" tg-height=\"450\" tg-width=\"635\" width=\"100%\"/><span>Data by YCharts</span></p><p class=\"t-img-caption\"><img height=\"auto\" src=\"https://static.tigerbbs.com/4ff983411a9b9571f66378eddc98653c\" tg-height=\"450\" tg-width=\"635\" width=\"100%\"/><span>Data by YCharts</span></p><p class=\"t-img-caption\"><img height=\"auto\" src=\"https://static.tigerbbs.com/259a902789541a798fdf388cf46d6b37\" tg-height=\"450\" tg-width=\"635\" width=\"100%\"/><span>Data by YCharts</span></p><p>The comparisons between these three relatively new biotechs with COVID-19 vaccines already shipping, shows Moderna is the most highly valued stock but BioNTech has the best revenue growth and operating margins. Going strictly by value, BioNTech is probably the best buy but in reality, all three companies are biotechs, in which one hit product or one large dismal failure can change the fortunes of the company. I view all three companies as very speculative, even with the success achieved by producing solutions for the COVID-19 pandemic.</p><p>I am not a big fan of trying to use valuation techniques on any biotech company. There is simply no way to value the future potential success or failure of the bets that many biotech companies make. If Moderna is part of curing solid tumor cancer, for instance, Moderna's current valuation will be viewed in hindsight as being way too low. If most of Moderna's pipeline fails then the valuation will be viewed in hindsight as being way too high.</p><p><b>Conclusion</b></p><p>Moderna is a high risk, high reward bet on mRNA technology succeeding in either preventing or curing many difficult to treat diseases. This is a stock that is strictly for long-term aggressive growth investors that are interested in speculating on potential home-run type products over a five-to-ten-year time frame. The risk that Moderna is only a one-product company is somewhat mitigated by the fact that the efficacy of the COVID-19 vaccine was so high, that is serves as a kind of proof of concept that a mRNA platform can produce other novel ways of addressing other difficult diseases.</p><p>The 58% pullback from Moderna's all-time high of $497.49 gives aggressive growth investors a chance to buy into a company with significant potential upside. However, risk averse or investors sensitive to short-term price movements should avoid Moderna's stock for now because there is significant downside risk if COVID-19 revenue drops off too rapidly before Moderna can show that it can achieve similar success in addressing other diseases.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>Moderna: High Upside Potential At Current Prices</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna: High Upside Potential At Current Prices\n</h2>\n<h4 class=\"meta\">\n\n\n2022-01-17 17:42 GMT+8   <a href=\"https://seekingalpha.com/article/4479930-moderna-high-upside-potential-at-current-prices\"><strong>Seeking Alpha</strong></a>\n</h4>\n</header>\n<article>\n<div>\n<p>SummaryModerna has a significant first mover competitive advantage by not only developing the COVID-19 vaccine but also by scaling the company's mRNA manufacturing capacity.Moderna recently reported ...</p>\n<a href=\"https://seekingalpha.com/article/4479930-moderna-high-upside-potential-at-current-prices\">Web Link</a>\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://seekingalpha.com/article/4479930-moderna-high-upside-potential-at-current-prices","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1131862461","content_text":"SummaryModerna has a significant first mover competitive advantage by not only developing the COVID-19 vaccine but also by scaling the company's mRNA manufacturing capacity.Moderna recently reported the preliminary COVID-19 estimate for product sales in 2021 as being approximately $17.5 billion.Recently, Singapore released data showing that COVID-19 deaths were the lowest among Moderna vaccine takers.One of the ways that Moderna is keeping ahead of potential mRNA competition is using its $15.3 billion in cash and $3.2 billion in Free Cash Flow to continue building out significant mRNA manufacturing capability across the world.The 58% pullback from Moderna's all-time high of $497.49 gives aggressive growth investors a chance to buy into a company with significant upside potential.Maddie Meyer/Getty Images NewsModerna (NASDAQ:MRNA) has extremely high upside from being a first mover in developing the world's most advanced mRNA platform. One of the most promising potential solutions for helping prevent or cure some of the most intractable diseases known to man is mRNA technology and Moderna has not only developed the most advanced mRNA platform but has also built out significant mRNA manufacturing capacity worldwide. There are many companies that are in various stages of developing mRNA technology but there are very few that have advanced as far as Moderna has in both developing mRNA technology, as well as having the manufacturing capacity and other commercial infrastructure to produce billions of doses of a vaccine per year. At this time, the only companies that have both the knowledge of advanced mRNA techniques and the manufacturing capacity to compete in the same arena as Moderna is the BioNTech (NASDAQ:BNTX) - Pfizer (NYSE:PFE) partnership.Moderna has a significant first mover competitive advantage by not only developing the COVID-19 vaccine but also by scaling the company's mRNA manufacturing capacity. It is one thing to produce mRNA in a lab setting but quite another to safely mass produce effective vaccines in regulator approved manufacturing sites around the world. Moderna's first mover advantage has translated into a very large war chest of cash from COVID-19 sales in which the company can use to further its lead by investing in advancing mRNA technology, improving mRNA manufacturing processes, and building out significant manufacturing capability worldwide. Moderna is also well along in developing one of the deepest drug pipelines in the world.While a first mover advantage is not exactly a moat, for the next several years at least, Moderna should enjoy a significant lead in developing many different mRNA-based therapies or vaccines to treat numerous difficult to treat diseases. Moderna currently has 40 different drug development programs, which is almost unheard of for such a relatively young biotech company that only two years ago was simply a research outfit. In the end, Moderna's mRNA platform and manufacturing capacity should result in significant long-term upside for investors buying into Moderna's stock today.Advantages of mRNA TechnologyThe reason why Moderna was able to rapidly develop a COVID-19 solution, while at the same time continuing to build out a significant number of drug development programs is because of the nature of mRNA technology.The development and manufacturing of mRNA for use as therapeuticsandvaccines are comparatively simple, scalableandextremely rapid.Source:Millapore SigmaThere are numerous advantages of a mRNA platform over traditional drug making. The major advantages of a mRNA platform that were demonstrated by the response to the COVID-19 pandemic was the ability to take the sequence of the virus and quickly move from development, to clinical trials, to approval, to mass manufacturing of a vaccine in a very rapid period of time. As Moderna and others get more experience and regulatory bodies get more comfortable with mRNA technology, I can see the day in the future where the response time of discovery of a virulent virus to clinical trials of a vaccine, to vaccine approval, to mass manufacturing of the vaccine could significantly shrink. Right now, it looks like it takes about 9 months to a year to move from virus discovery to eventually making it into people's arms. Eventually, this response time could shrink to matter of a few months.Omnicron was first identified as a variant around November 24, 2021. Moderna CEO Stéphane Bancel said in a CNBC interview that clinical trials for an Omnicron vaccine will start soon and a Omnicron vaccine should be available by fall. This type of rapid response to infectious diseases is unheard of before now and as time goes along, mRNA platform companies could not only become proficient in rapidly producing vaccines against specific viruses but also become proficient at producing vaccines against specific strains of a virus, in specific regions of the world. Among the reason why I think Moderna is building manufacturing capacity in different countries and regions of the world is because vaccines will eventually be less of a one size fits all countries and be more along the lines of regional manufacturing sites creating vaccines specific for the most prevalent viruses and strains of virus in that specific region.Another potential huge advantage of a mRNA platform is flexibility. Theoretically, a mRNA manufacturing plant can be relatively rapidly switched to producing any other mRNA-based drug. It is possible that a mRNA plant that makes COVID-19 vaccines could be rapidly switched to making an Ebola vaccine, for instance. This is in contrast to the manufacturing process of many traditional drugs that require a dedicated plant to produce a drug. This could make the CapEx involved for producing multiple different types of drugs, far lower than a traditional drug manufacturer.The COVID-19 pandemic has highlighted exactly how easy it is to change the vaccine simply by plugging the genetic sequence of any virus that Moderna wants to target right into its basic mRNA platform. This is not only useful for being able to attack different strains of COVID-19 but also means that Moderna has the ability of using the sequence of any virus whether that be the flu, HIV, CMV, Tuberculosis, Zika, or Rabies and quickly produce a vaccine ready for testing.COVID-19 ProgressCOVID-19 has totally changed the fortunes of Moderna within just two years. Up until 2020, Moderna was only a little-known drug research outfit that had very little revenues but being the second company to bring a viable vaccine to protect against COVID-19 into US markets, has made Moderna very widely known worldwide and the company has built a huge brand that is on the verge of becoming a giant within the drug industry.There is real world evidence that up until now, Moderna has produced the most effective COVID-19 vaccine. Data from all over the world supports the very strong efficacy that was shown in phase III data in the USA. Recently, Singapore released data showing that COVID-19 deaths were lowest among Moderna takers. Singapore had 802 deaths out of which 70% were unvaccinated. Between Moderna, Pfizer-BioNTech, Sinopharm and Sinovac vaccines, Moderna had the least death rates:11 deaths per 100,000: Sinovac7.8 deaths per 100,000: Sinopharm6.2 deaths per 100,000: Pfizer/BioNTech1 death per 100,000: ModernaOver the course of 2021, Moderna shipped 807 million doses of Spikevax, Moderna's COVID-19 vaccine, to many different locations around the world, with around 25% of those doses going to low-income and middle-income countries. Moderna reported recently during the JPMorgan 40th Annual Healthcare Conference on January 10th, that the preliminary estimate for Spikevax product sales in 2021 is around $17.5 billion.Because of the huge demand for Moderna's vaccine worldwide, for a decent part of 2021, the company was supply constrained but that situation is beginning to turn around now. Moderna CEO Stephane Bancel attributes the reason for supply constraints as Moderna having a higher dose than the Pfizer-BioNTech vaccine. The higher dose was a big drain on manufacturing resources. Moderna has since built out additional manufacturing capacity over the course of 2021 and is now in much better shape to address COVID-19 demand. In Q4, Moderna shipped 300 million doses, which is a run rate of 1.2 billion doses. Moderna believes that they can produce two billion to three billion doses of boosters over the course of 2022, if necessary.Moderna Spikevax advanced purchase agreementsBecause COVID-19 vaccine makers have lately been having to play whack-a-mole with new variants, the demand for Spikevax is still rising. As can be seen from the above graphic, from November 4th to January 10th, Moderna has gained and additional $1.5 billion in advanced purchase agreements (\"APA\") and $0.5 Billion in options, with those numbers being mostly heavily weighted toward the first half of the year. Moderna is still having ongoing discussions with many countries about whether additional vaccines will need to be added to address the fall moving into winter of '22. I expect that when all is said and done, Moderna could wind up signing additional APAs over the course of the year. So, it looks like 2022 might again be another banner year for Moderna.How COVID-19 is likely to evolveCurrently, the world is in the midst of variant reinfection waves, which will likely continue throughout 2022 but by 2023 COVID-19 should become more seasonal and endemic. Morbidity waves are expected to become lower and lower over the next several years and there is a good chance that COVID-19 will be seen more like the flu is perceived today within a year or two. Post-pandemic, COVID-19 is expected to mostly only affect people aged 50-plus, health care workers, immunocompromised people and other high-risk populations. These groups will likely need boosters to ensure that they do not get severe disease and hospitalization. As COVID-19 winds down, demand for Spikevax will probably begin dropping in the 2023-to-2024-time frame. This is why some people have been predicting revenue declines for Moderna. Well, what is Moderna's post pandemic plan to replace the likely COVID-19 vaccine declining revenues?Moderna's Plan Moving ForwardModerna Product Strategy in 2022The initial way that Moderna plans on countering the likely COVID-19 vaccine decline is by bundling different seasonal respiratory vaccines together into just one vaccine. The days of getting COVID-19 specific vaccine seem to be waning and a pan-respiratory vaccine will likely compete extremely effectively with any laggards coming to the market late with only a COVID-19 solution.Moderna vision for pan-respiratory vaccineModerna's vision is that an annual single-dose pan-respiratory booster can be customized to fit different demographics, different geographies, and different respiratory diseases over time. Eventually, Moderna even expects to target specific strains of respiratory diseases in specific regions. I wouldn't be surprised if a pan-respiratory vaccine starts to appear within two years.Moderna Strategy After COVID-19Unlike vaccine technology from companies like Novavax (NASDAQ:NVAX), mRNA can be used for many other different purposes besides infectious diseases.Novavax's pipeline only consists of 9 programs that target 5 other infectious diseases other than COVID-19. Most of Novavax's pipeline is mostly concerned with respiratory diseases, with only one direct contact latent virus, Ebola, appearing on the list.In contrast, Moderna is much further ahead in developing solutions against multiple latent viruses that are a lot more prevalent than Ebola. The first ones being targeted and are already in clinical trials are CMV and EBV, with HIV soon to begin trials. CMV is Moderna's most advanced drug in the pipeline and the first patient has already been dosed in phase III trials. Besides CMV, EBV, and HIV, there a many other undisclosed latent viruses being worked on in the labs.The next area that Moderna is prioritizing is in developing therapeutics using mRNA technology which allows the company to produce oncology products, cardio products, rare genetic disease products and autoimmune disease products. This is an area that has significant upside for Moderna. Moderna will be using totally new approaches to develop solutions against cancer and develop solutions for diseases that currently have no significant solutions. Recently, Moderna formed a partnership with Carisma Therapeutics. Moderna plans to combine its mRNA technology with Carisma Therapeutics' engineered macrophage technology to develop solutions against solid tumor cancer. The reason why this is important is because while autologous CAR-Ts have really good data in Heme malignancies, which are blood cancers, they have not been very effective in solid tumors and eighty percent of cancer patients die of solid tumors. I won't go deep into the science behind it but scientist know the reasons why CAR-Ts are not as effective with solid tumors, and both companies think Carisma Therapeutics' CAR-Macrophage's technology combined with mRNA technology can produce revolutionary new ways to essentially cure the most prevalent and difficult to treat form of cancer deaths which are solid tumors.Moderna's deep expertise in mRNA and LNP technologies opens up a potentially game-changing opportunity for engineered macrophages. In vivo delivery directly to monocytes and macrophages enables an off-the-shelf therapeutic approach that uses the patients' own cells to provide a truly personalized treatment.Source: Steven Kelly, President and Chief Executive Officer of CarismaRight now, there is no way to factor in the upside of Moderna potentially developing a significantly better solution to attacking and possibly curing solid tumor cancer. The therapies that could come out of partnerships like the one Moderna has with Carisma could potentially produce home runs just as big, if not bigger than the COVID-19 vaccine.The fourth area that Moderna is developing solutions using gene-editing enzymes. Moderna has only seriously got into gene editing relatively recently when the company signed a collaboration with Metagenomi. For those unaware,gene-editing is the same strategy that companies like Editas (NASDAQ:EDIT) and CRISPR Therapeutics (NASDAQ:CRSP) are pursuing. The focus for the Metagenomi collaboration will be on serious genetic diseases.Moderna capital allocation prioritiesModerna has already started spending its huge cash flows derived from COVID-19 vaccine sales. I just wanted to include the above slide in this article because it shows that Moderna's number one capital allocation priority is investing in R&D, manufacturing infrastructure and continuing to build out the company's commercial infrastructure. The second priority is investing in external investment opportunities, either in the form of collaborations or M&A. The collaborations with Metagenomi and Carisma Therapeutics are examples of this second priority.Manufacturing CapacityModerna In-country vaccine manufacturingThere is a rather large set of existing potential competitors to Moderna and there are also countries like India that are supporting rising home-grown mRNA platform companies. One of the ways that Moderna is keeping ahead of such efforts from competitors is using its $15.3 billion in cash and $3.2 billion in Free Cash Flow at the end of Q3, to build out significant mRNA manufacturing capability across the world. Moderna has announced in principle agreements with Australia and Canadato build out mRNA vaccine manufacturing plants within those countries. These announcements are in addition to the plans to build a factory capable of producing up to 500 million vaccine doses in Africa each year. I believe Moderna is still in the process of choosing which African country the manufacturing site will be located in.RisksThe major risk that Moderna faces in the short term is revenue from the COVID-19 declining faster than Moderna can get other vaccines or therapies on to market and show superior results. The closest drug to approval is a CMV vaccine. An approval of the CMV vaccine would likely shoot Moderna's stock higher because it would show that mRNA is viable for addressing other diseases. A CMV rejection would likely drop Moderna's stock much lower.Another major risk for Moderna are patent disputes and lawsuits. Moderna recently had to back down in a dispute with the NIH over COVID-19 patents and Moderna could also soon face a patent infringement lawsuit from Arbutus (NASDAQ:ABUS) over the COVID-19 vaccine. Currently, it is unknown how these disputes will impact Moderna over the longer term.Analyst Price TargetsModerna Analyst Price TargetsThe above is based on 15 Wall Street analysts offering 12-month price targets for Moderna in the last 3 months. The average price target is $289.07 with a high forecast of $506.00 and a low forecast of $86.00. The average price target represents a 38% increase from the last price of $210.17.ValuationData by YChartsData by YChartsData by YChartsThe comparisons between these three relatively new biotechs with COVID-19 vaccines already shipping, shows Moderna is the most highly valued stock but BioNTech has the best revenue growth and operating margins. Going strictly by value, BioNTech is probably the best buy but in reality, all three companies are biotechs, in which one hit product or one large dismal failure can change the fortunes of the company. I view all three companies as very speculative, even with the success achieved by producing solutions for the COVID-19 pandemic.I am not a big fan of trying to use valuation techniques on any biotech company. There is simply no way to value the future potential success or failure of the bets that many biotech companies make. If Moderna is part of curing solid tumor cancer, for instance, Moderna's current valuation will be viewed in hindsight as being way too low. If most of Moderna's pipeline fails then the valuation will be viewed in hindsight as being way too high.ConclusionModerna is a high risk, high reward bet on mRNA technology succeeding in either preventing or curing many difficult to treat diseases. This is a stock that is strictly for long-term aggressive growth investors that are interested in speculating on potential home-run type products over a five-to-ten-year time frame. The risk that Moderna is only a one-product company is somewhat mitigated by the fact that the efficacy of the COVID-19 vaccine was so high, that is serves as a kind of proof of concept that a mRNA platform can produce other novel ways of addressing other difficult diseases.The 58% pullback from Moderna's all-time high of $497.49 gives aggressive growth investors a chance to buy into a company with significant potential upside. However, risk averse or investors sensitive to short-term price movements should avoid Moderna's stock for now because there is significant downside risk if COVID-19 revenue drops off too rapidly before Moderna can show that it can achieve similar success in addressing other diseases.","news_type":1},"isVote":1,"tweetType":1,"viewCount":382,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":697867661,"gmtCreate":1642408017755,"gmtModify":1642408018044,"author":{"id":"4089812543711440","authorId":"4089812543711440","name":"Tiramisu2020","avatar":"https://static.tigerbbs.com/c7923aecbb67682b46eed9d583bc08c3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089812543711440","authorIdStr":"4089812543711440"},"themes":[],"htmlText":"cool","listText":"cool","text":"cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/697867661","repostId":"2203855742","repostType":4,"isVote":1,"tweetType":1,"viewCount":484,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":697867877,"gmtCreate":1642407988540,"gmtModify":1642407988836,"author":{"id":"4089812543711440","authorId":"4089812543711440","name":"Tiramisu2020","avatar":"https://static.tigerbbs.com/c7923aecbb67682b46eed9d583bc08c3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089812543711440","authorIdStr":"4089812543711440"},"themes":[],"htmlText":"cool","listText":"cool","text":"cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/697867877","repostId":"2203855742","repostType":4,"isVote":1,"tweetType":1,"viewCount":783,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":697864401,"gmtCreate":1642407681264,"gmtModify":1642407681557,"author":{"id":"4089812543711440","authorId":"4089812543711440","name":"Tiramisu2020","avatar":"https://static.tigerbbs.com/c7923aecbb67682b46eed9d583bc08c3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089812543711440","authorIdStr":"4089812543711440"},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/697864401","repostId":"694689903","repostType":1,"repost":{"id":694689903,"gmtCreate":1641954512960,"gmtModify":1641959394973,"author":{"id":"4087984885325640","authorId":"4087984885325640","name":"言财美股研究社","avatar":"https://static.tigerbbs.com/4e4b8de7e5193af177d4fd115494e4a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087984885325640","authorIdStr":"4087984885325640"},"themes":[],"title":"加息与缩表会是决定价值股跑赢科技成长股的信号枪吗？","htmlText":"导读：近期，美股成长股在taper、加息与缩表等一轮的货币正常化操作预期急剧升温之下迎来了暴跌，以纳斯达克为代表的科技股表现尤为惨烈，甚至创下了2000年科网泡沫破灭以来的最差表现，可谓是步步惊心，在市场暴跌之际，美股投资者的信心也在剧烈动摇，加息与缩表会戳破美股的牛市泡沫，从而将美股带向牛市谢幕演出，那么关键点就来了：&nbsp;1. 美股当下的泡沫真的很大吗？估值分位数如何？盈利预期如何？2. 这一次缩表的规模会有多大？上一次缩表的规模有多大？3. 加息与缩表真的是美股牛市的天敌吗？美股就必然会跌入熊市吗？接下来，我们将具体分析。上一轮货币正常化阶段的股市走势回顾美联储的上一轮货币正常化路径及重要时间节点及美股表现回顾：图 纳斯达克走势与美联储联邦基金利率走势叠加（粉色代表联邦基金利率）&nbsp;①2013-05-22，联储主席伯南克表示会削减QE3，正式开始货币正常化的进程；②2013年10月，缩减购债Taper预期升温，并从2013年12月18日开始Taper③2014年10月29日，宣布QE3结束，从实施taper到QE3结束，实际上花了10个月的时间；④在taper结束以后，美联储开始酝酿加息，并在2015年12月15日进行了美联储的首次加息，将联邦基金利率从0.15%上调整至0.37%。在首次加息之前，纳斯达克表现一直相对强势，反而是在12月首次加息之后，美股才开始一轮调整，从2015-12-15到2016年2月9日，纳斯达克调整幅度接近14%，二月份企稳以后开始新一轮上行。图 纳斯达克2015年12月15日首次加息前后股价走势⑤加息之后的缩表：在加息一年多以后，2017年4月5日美联储开始释放出缩表的信号，此时距离第一次加息(2015-12-15)，时间过去了16个月，联邦基金日利率从0.15%调升至0.91%，2017年5月24日，联储提出要进行定量式缩","listText":"导读：近期，美股成长股在taper、加息与缩表等一轮的货币正常化操作预期急剧升温之下迎来了暴跌，以纳斯达克为代表的科技股表现尤为惨烈，甚至创下了2000年科网泡沫破灭以来的最差表现，可谓是步步惊心，在市场暴跌之际，美股投资者的信心也在剧烈动摇，加息与缩表会戳破美股的牛市泡沫，从而将美股带向牛市谢幕演出，那么关键点就来了：&nbsp;1. 美股当下的泡沫真的很大吗？估值分位数如何？盈利预期如何？2. 这一次缩表的规模会有多大？上一次缩表的规模有多大？3. 加息与缩表真的是美股牛市的天敌吗？美股就必然会跌入熊市吗？接下来，我们将具体分析。上一轮货币正常化阶段的股市走势回顾美联储的上一轮货币正常化路径及重要时间节点及美股表现回顾：图 纳斯达克走势与美联储联邦基金利率走势叠加（粉色代表联邦基金利率）&nbsp;①2013-05-22，联储主席伯南克表示会削减QE3，正式开始货币正常化的进程；②2013年10月，缩减购债Taper预期升温，并从2013年12月18日开始Taper③2014年10月29日，宣布QE3结束，从实施taper到QE3结束，实际上花了10个月的时间；④在taper结束以后，美联储开始酝酿加息，并在2015年12月15日进行了美联储的首次加息，将联邦基金利率从0.15%上调整至0.37%。在首次加息之前，纳斯达克表现一直相对强势，反而是在12月首次加息之后，美股才开始一轮调整，从2015-12-15到2016年2月9日，纳斯达克调整幅度接近14%，二月份企稳以后开始新一轮上行。图 纳斯达克2015年12月15日首次加息前后股价走势⑤加息之后的缩表：在加息一年多以后，2017年4月5日美联储开始释放出缩表的信号，此时距离第一次加息(2015-12-15)，时间过去了16个月，联邦基金日利率从0.15%调升至0.91%，2017年5月24日，联储提出要进行定量式缩","text":"导读：近期，美股成长股在taper、加息与缩表等一轮的货币正常化操作预期急剧升温之下迎来了暴跌，以纳斯达克为代表的科技股表现尤为惨烈，甚至创下了2000年科网泡沫破灭以来的最差表现，可谓是步步惊心，在市场暴跌之际，美股投资者的信心也在剧烈动摇，加息与缩表会戳破美股的牛市泡沫，从而将美股带向牛市谢幕演出，那么关键点就来了： 1. 美股当下的泡沫真的很大吗？估值分位数如何？盈利预期如何？2. 这一次缩表的规模会有多大？上一次缩表的规模有多大？3. 加息与缩表真的是美股牛市的天敌吗？美股就必然会跌入熊市吗？接下来，我们将具体分析。上一轮货币正常化阶段的股市走势回顾美联储的上一轮货币正常化路径及重要时间节点及美股表现回顾：图 纳斯达克走势与美联储联邦基金利率走势叠加（粉色代表联邦基金利率） ①2013-05-22，联储主席伯南克表示会削减QE3，正式开始货币正常化的进程；②2013年10月，缩减购债Taper预期升温，并从2013年12月18日开始Taper③2014年10月29日，宣布QE3结束，从实施taper到QE3结束，实际上花了10个月的时间；④在taper结束以后，美联储开始酝酿加息，并在2015年12月15日进行了美联储的首次加息，将联邦基金利率从0.15%上调整至0.37%。在首次加息之前，纳斯达克表现一直相对强势，反而是在12月首次加息之后，美股才开始一轮调整，从2015-12-15到2016年2月9日，纳斯达克调整幅度接近14%，二月份企稳以后开始新一轮上行。图 纳斯达克2015年12月15日首次加息前后股价走势⑤加息之后的缩表：在加息一年多以后，2017年4月5日美联储开始释放出缩表的信号，此时距离第一次加息(2015-12-15)，时间过去了16个月，联邦基金日利率从0.15%调升至0.91%，2017年5月24日，联储提出要进行定量式缩","images":[{"img":"https://static.tigerbbs.com/e31e48604967a92ce19c666364242412","width":"640","height":"426"}],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/694689903","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":16,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":526,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":697864572,"gmtCreate":1642407629708,"gmtModify":1642407630021,"author":{"id":"4089812543711440","authorId":"4089812543711440","name":"Tiramisu2020","avatar":"https://static.tigerbbs.com/c7923aecbb67682b46eed9d583bc08c3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089812543711440","authorIdStr":"4089812543711440"},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/697864572","repostId":"694951908","repostType":1,"repost":{"id":694951908,"gmtCreate":1641793721698,"gmtModify":1642042398865,"author":{"id":"3502767768442965","authorId":"3502767768442965","name":"话题虎","avatar":"https://static.tigerbbs.com/d418c2def5dc1d094b03270b450f71ce","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3502767768442965","authorIdStr":"3502767768442965"},"themes":[],"title":"“女巴菲特”彻底栽了，木头姐一年回撤40%！仍然再加仓！","htmlText":"木头姐，真名凯瑟琳·伍德（Cathie Wood），在58岁时创立了方舟投资（ARK Investment），专注于“破坏性创新”，风格侧重极致成长，长期重仓科技股。 在2020年，Cathie&nbsp;Wood因持续重金押注特斯拉而一战成名，ARK旗下多达5只ETF平均回报率超过了140%！由此，被称为“女版巴菲特”。 然而，在2021年，Cathie&nbsp;Wood&nbsp;失败了。 这一年中，ARKK持仓的股票中，超8成股票近一年回撤超过40%，其中第二大重仓股回撤超过70%！ 随着今年美国加息临近，对科技股的承压越来越大。而Wood正式专注于投资“颠覆式创新”科技企业，所以，2022年才刚开始，<a target=\"_blank\" href=\"https://laohu8.com/S/ARKK\">$ARK Innovation ETF(ARKK)$</a> 就暴跌了10.75%: 据CNBC统计，ARKK持有的43只股票中，有36只较近一年高点下跌了40%以上，目前十大重仓股如下： <a target=\"_blank\" href=\"https://laohu8.com/S/TSLA\">$特斯拉(TSLA)$</a>/ <a target=\"_blank\" href=\"https://laohu8.com/S/ZM\">$Zoom(ZM)$</a> /<a target=\"_blank\" href=\"https://laohu8.com/S/ROKU\">$Roku Inc(ROKU)$</a> /<a target=\"_blank\" href=\"https://laohu8.com/S/TDOC\">$Teladoc Health Inc.(TDOC)$</a> /","listText":"木头姐，真名凯瑟琳·伍德（Cathie Wood），在58岁时创立了方舟投资（ARK Investment），专注于“破坏性创新”，风格侧重极致成长，长期重仓科技股。 在2020年，Cathie&nbsp;Wood因持续重金押注特斯拉而一战成名，ARK旗下多达5只ETF平均回报率超过了140%！由此，被称为“女版巴菲特”。 然而，在2021年，Cathie&nbsp;Wood&nbsp;失败了。 这一年中，ARKK持仓的股票中，超8成股票近一年回撤超过40%，其中第二大重仓股回撤超过70%！ 随着今年美国加息临近，对科技股的承压越来越大。而Wood正式专注于投资“颠覆式创新”科技企业，所以，2022年才刚开始，<a target=\"_blank\" href=\"https://laohu8.com/S/ARKK\">$ARK Innovation ETF(ARKK)$</a> 就暴跌了10.75%: 据CNBC统计，ARKK持有的43只股票中，有36只较近一年高点下跌了40%以上，目前十大重仓股如下： <a target=\"_blank\" href=\"https://laohu8.com/S/TSLA\">$特斯拉(TSLA)$</a>/ <a target=\"_blank\" href=\"https://laohu8.com/S/ZM\">$Zoom(ZM)$</a> /<a target=\"_blank\" href=\"https://laohu8.com/S/ROKU\">$Roku Inc(ROKU)$</a> /<a target=\"_blank\" href=\"https://laohu8.com/S/TDOC\">$Teladoc Health Inc.(TDOC)$</a> /","text":"木头姐，真名凯瑟琳·伍德（Cathie Wood），在58岁时创立了方舟投资（ARK Investment），专注于“破坏性创新”，风格侧重极致成长，长期重仓科技股。 在2020年，Cathie Wood因持续重金押注特斯拉而一战成名，ARK旗下多达5只ETF平均回报率超过了140%！由此，被称为“女版巴菲特”。 然而，在2021年，Cathie Wood 失败了。 这一年中，ARKK持仓的股票中，超8成股票近一年回撤超过40%，其中第二大重仓股回撤超过70%！ 随着今年美国加息临近，对科技股的承压越来越大。而Wood正式专注于投资“颠覆式创新”科技企业，所以，2022年才刚开始，$ARK Innovation ETF(ARKK)$ 就暴跌了10.75%: 据CNBC统计，ARKK持有的43只股票中，有36只较近一年高点下跌了40%以上，目前十大重仓股如下： $特斯拉(TSLA)$/ $Zoom(ZM)$ /$Roku Inc(ROKU)$ /$Teladoc Health Inc.(TDOC)$ /","images":[{"img":"https://static.tigerbbs.com/17484061ae2bbb6fd04a8e2c1351b32a","width":"554","height":"768"},{"img":"https://static.tigerbbs.com/6dc9f966dc410691ecee378c5f2b37cd","width":"600","height":"333"},{"img":"https://static.tigerbbs.com/bda339a03252c66e3ce4aa0f8575092e","width":"840","height":"470"}],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/694951908","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"subType":2,"comments":[],"imageCount":3,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":688,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":840720071,"gmtCreate":1635691016838,"gmtModify":1635691016949,"author":{"id":"4089812543711440","authorId":"4089812543711440","name":"Tiramisu2020","avatar":"https://static.tigerbbs.com/c7923aecbb67682b46eed9d583bc08c3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089812543711440","authorIdStr":"4089812543711440"},"themes":[],"htmlText":"Welcome Meta","listText":"Welcome Meta","text":"Welcome Meta","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":11,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/840720071","repostId":"1104228860","repostType":4,"isVote":1,"tweetType":1,"viewCount":237,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":863549629,"gmtCreate":1632407990161,"gmtModify":1632731117215,"author":{"id":"4089812543711440","authorId":"4089812543711440","name":"Tiramisu2020","avatar":"https://static.tigerbbs.com/c7923aecbb67682b46eed9d583bc08c3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089812543711440","authorIdStr":"4089812543711440"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":11,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/863549629","repostId":"2169664162","repostType":4,"isVote":1,"tweetType":1,"viewCount":142,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":881242384,"gmtCreate":1631351614948,"gmtModify":1631888660515,"author":{"id":"4089812543711440","authorId":"4089812543711440","name":"Tiramisu2020","avatar":"https://static.tigerbbs.com/c7923aecbb67682b46eed9d583bc08c3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089812543711440","authorIdStr":"4089812543711440"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/881242384","repostId":"1127699574","repostType":4,"repost":{"id":"1127699574","kind":"news","pubTimestamp":1631328152,"share":"https://www.laohu8.com/m/news/1127699574?lang=&edition=full","pubTime":"2021-09-11 10:42","market":"us","language":"en","title":"BlackBerry Has a Chance at Turning Into a Growth Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=1127699574","media":"InvestorPlace","summary":"BB stock could be worth 30% more, assuming the company turns FCF positive next fiscal year","content":"<html><body><p><b>Blackberry</b> (NYSE:<b><u>BB</u></b>), the automotive embedded software company, produced positive free cash flow (FCF) of $74 million last fiscal year ending May 31. But its fiscal Q1 showed a loss of $35 million in FCF. This didn’t do anything to help BB stock. If fell from a near-term peak of $15.88 on June 3 (before the June 24 Q1 results) to $9.56 on Aug. 19. The stock could be near a trough now.</p>\n<p>I still believe that as I wrote on June 4, BB stock could be worth $20.91 per share, assuming its FCF turns positive this year. All eyes will therefore be on its upcoming Sept. 22 fiscal Q2 earnings release. Investors will want to see if revenue is growing and the company achieves positive FCF.</p>\n<p>For example, last quarter ending May 31 revenue fell by 15.5% year-over-year (YOY) from $206 million last year to $174 million this quarter. In fact, it was also down by 17.1% from the prior quarter as well.</p>\n<p>That is almost like a curse for a stock like Blackberry. Investors and analysts want to see positive growth on a steady YoY and quarter-over-quarter (QOQ) basis. This probably explains why the stock fell so much.</p>\n<p><b>Where This Leaves BlackBerry</b></p>\n<p>Last year BlackBerry produced $893 million in revenue, but for this fiscal year ending May 2022 analysts still see lower sales at $781.6 million. However, they also expect a recovery by May 2023 to $954.1 million. But is the market willing to wait until then? That is why the upcoming fiscal Q2 2022 earnings release will be so important. Investors want to see if the company is back on a growth track.</p>\n<p>If it is, then the likelihood that it can produce positive free cash flow for the year will increase, and this will help BB stock recover.</p>\n<p>For example, as I pointed out in my last article, BlackBerry reported FCF during Q4 of $49 million. This was a huge 23.33% of its $210 million in revenue during the quarter. Assuming it can pull off the same thing next year the company could make $222.3 million in FCF that year. That is based on 23.33% of sales of $954.1 million.</p>\n<p>However, to be more conservative let’s assume that it can only make half of that or an 11.5% FCF margin. That lowers its forecast FCF to $109.7 million. Moreover, its present value using a 10% discount rate and a year and a half in the future is 86.68% times this FCF number. That lowers it to $95.1 million.</p>\n<p><b>What BlackBerry Stock Could Be Worth</b></p>\n<p>If we use an FCF yield of between 1% we can calculate the company’s ongoing value. This is calculated by dividing the free cash flow estimates by its FCF yield ratio.</p>\n<p>For example, using $95.1 million in FCF forecast for Blackberry in 2023 brings its value to $9.51 billion. This is 55.7% over today’s market value for Blackberry of $6.109 billion.</p>\n<p>And if we use a 1.5% FCF yield, the target market value falls to $6.34 billion (i.e., $95.1/0.015=$6.34b). That is just 3.78% over today’s price.</p>\n<p>Therefore, BB stock has a target value between 3.78% and 55.7% over today’s price. The average is 29.74%, or basically 30% over today’s price of $10.73. That puts its value at $13.95 per share (estimate rounded to $14).</p>\n<p><b>What to do With BB Stock</b></p>\n<p>Analysts are not very positive about BB stock. For example, seven analysts surveyed by Refinitiv (reported by <i>Yahoo! Finance</i>) have an average target price of $8.36. That implies a potential drop of 22% from today’s price.</p>\n<p>Another survey by <i>TipRanks.com</i> says that four analysts have an average price of $9.50or 11.5% below today’s price. However, nine Wall Street analysts surveyed by <i>Seeking Alpha</i> have an average target of $8.19, or 23.7% below today.</p>\n<p>So the average of all three of these surveys is a price of $8.68, or 19% lower. I would not be too bothered by this though. Analysts have a tendency to raise their price targets after the stock has already risen.</p>\n<p>Enterprising investors who are willing to anticipate more positive results for the year ending May 2023 (and probably before that) could see the stock rise 30% to $13.95 per share.</p></body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>BlackBerry Has a Chance at Turning Into a Growth Stock</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBlackBerry Has a Chance at Turning Into a Growth Stock\n</h2>\n<h4 class=\"meta\">\n\n\n2021-09-11 10:42 GMT+8   <a href=\"https://investorplace.com/2021/09/bb-stock-could-turn-around-next-fiscal-year-if-revenue-rebounds-as-analysts-forecast/\"><strong>InvestorPlace</strong></a>\n</h4>\n</header>\n<article>\n<div>\n<p>Blackberry (NYSE:BB), the automotive embedded software company, produced positive free cash flow (FCF) of $74 million last fiscal year ending May 31. But its fiscal Q1 showed a loss of $35 million in ...</p>\n<a href=\"https://investorplace.com/2021/09/bb-stock-could-turn-around-next-fiscal-year-if-revenue-rebounds-as-analysts-forecast/\">Web Link</a>\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BB":"黑莓"},"source_url":"https://investorplace.com/2021/09/bb-stock-could-turn-around-next-fiscal-year-if-revenue-rebounds-as-analysts-forecast/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1127699574","content_text":"Blackberry (NYSE:BB), the automotive embedded software company, produced positive free cash flow (FCF) of $74 million last fiscal year ending May 31. But its fiscal Q1 showed a loss of $35 million in FCF. This didn’t do anything to help BB stock. If fell from a near-term peak of $15.88 on June 3 (before the June 24 Q1 results) to $9.56 on Aug. 19. The stock could be near a trough now.\nI still believe that as I wrote on June 4, BB stock could be worth $20.91 per share, assuming its FCF turns positive this year. All eyes will therefore be on its upcoming Sept. 22 fiscal Q2 earnings release. Investors will want to see if revenue is growing and the company achieves positive FCF.\nFor example, last quarter ending May 31 revenue fell by 15.5% year-over-year (YOY) from $206 million last year to $174 million this quarter. In fact, it was also down by 17.1% from the prior quarter as well.\nThat is almost like a curse for a stock like Blackberry. Investors and analysts want to see positive growth on a steady YoY and quarter-over-quarter (QOQ) basis. This probably explains why the stock fell so much.\nWhere This Leaves BlackBerry\nLast year BlackBerry produced $893 million in revenue, but for this fiscal year ending May 2022 analysts still see lower sales at $781.6 million. However, they also expect a recovery by May 2023 to $954.1 million. But is the market willing to wait until then? That is why the upcoming fiscal Q2 2022 earnings release will be so important. Investors want to see if the company is back on a growth track.\nIf it is, then the likelihood that it can produce positive free cash flow for the year will increase, and this will help BB stock recover.\nFor example, as I pointed out in my last article, BlackBerry reported FCF during Q4 of $49 million. This was a huge 23.33% of its $210 million in revenue during the quarter. Assuming it can pull off the same thing next year the company could make $222.3 million in FCF that year. That is based on 23.33% of sales of $954.1 million.\nHowever, to be more conservative let’s assume that it can only make half of that or an 11.5% FCF margin. That lowers its forecast FCF to $109.7 million. Moreover, its present value using a 10% discount rate and a year and a half in the future is 86.68% times this FCF number. That lowers it to $95.1 million.\nWhat BlackBerry Stock Could Be Worth\nIf we use an FCF yield of between 1% we can calculate the company’s ongoing value. This is calculated by dividing the free cash flow estimates by its FCF yield ratio.\nFor example, using $95.1 million in FCF forecast for Blackberry in 2023 brings its value to $9.51 billion. This is 55.7% over today’s market value for Blackberry of $6.109 billion.\nAnd if we use a 1.5% FCF yield, the target market value falls to $6.34 billion (i.e., $95.1/0.015=$6.34b). That is just 3.78% over today’s price.\nTherefore, BB stock has a target value between 3.78% and 55.7% over today’s price. The average is 29.74%, or basically 30% over today’s price of $10.73. That puts its value at $13.95 per share (estimate rounded to $14).\nWhat to do With BB Stock\nAnalysts are not very positive about BB stock. For example, seven analysts surveyed by Refinitiv (reported by Yahoo! Finance) have an average target price of $8.36. That implies a potential drop of 22% from today’s price.\nAnother survey by TipRanks.com says that four analysts have an average price of $9.50or 11.5% below today’s price. However, nine Wall Street analysts surveyed by Seeking Alpha have an average target of $8.19, or 23.7% below today.\nSo the average of all three of these surveys is a price of $8.68, or 19% lower. I would not be too bothered by this though. Analysts have a tendency to raise their price targets after the stock has already risen.\nEnterprising investors who are willing to anticipate more positive results for the year ending May 2023 (and probably before that) could see the stock rise 30% to $13.95 per share.","news_type":1},"isVote":1,"tweetType":1,"viewCount":185,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":810172661,"gmtCreate":1629957794253,"gmtModify":1631893593952,"author":{"id":"4089812543711440","authorId":"4089812543711440","name":"Tiramisu2020","avatar":"https://static.tigerbbs.com/c7923aecbb67682b46eed9d583bc08c3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089812543711440","authorIdStr":"4089812543711440"},"themes":[],"htmlText":"Latest","listText":"Latest","text":"Latest","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/810172661","repostId":"1197778368","repostType":4,"isVote":1,"tweetType":1,"viewCount":167,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":605460975,"gmtCreate":1639219772458,"gmtModify":1639219772709,"author":{"id":"4089812543711440","authorId":"4089812543711440","name":"Tiramisu2020","avatar":"https://static.tigerbbs.com/c7923aecbb67682b46eed9d583bc08c3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089812543711440","authorIdStr":"4089812543711440"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/605460975","repostId":"2190205546","repostType":4,"isVote":1,"tweetType":1,"viewCount":156,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":873711260,"gmtCreate":1636986667327,"gmtModify":1636986667426,"author":{"id":"4089812543711440","authorId":"4089812543711440","name":"Tiramisu2020","avatar":"https://static.tigerbbs.com/c7923aecbb67682b46eed9d583bc08c3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089812543711440","authorIdStr":"4089812543711440"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/873711260","repostId":"1124063419","repostType":4,"repost":{"id":"1124063419","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1636981410,"share":"https://www.laohu8.com/m/news/1124063419?lang=&edition=full","pubTime":"2021-11-15 21:03","market":"us","language":"en","title":"Toplines Before US Market Open on Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=1124063419","media":"Tiger Newspress","summary":"Stock futures pointed to a higher open Monday morning as investors awaited key retail sales and earn","content":"<html><body><p>Stock futures pointed to a higher open Monday morning as investors awaited key retail sales and earnings results out from major U.S. companies later this week.<img referrerpolicy=\"no-referrer\" src=\"https://static.tigerbbs.com/9bd814193ce3a21c26ecb73c6e576fc6\" tg-height=\"511\" tg-width=\"1080\"/>At 8:00 a.m. ET, S&P 500 e-minis were up 10.75 points, or 0.23%, Nasdaq 100 e-minis were up 34.5 points, or 0.21%, and Dow e-minis  were up 118 points, or 0.33%.</p>\n<p>Investors this week are also set to receive new data from the Commerce Department on U.S. retail sales. The report is likely to show a 1.3% month-on-month jump in sales for October after a more sanguine 0.7% rise in September. And retail earnings results from major names including Walmart, Target, Home Depot and Lowe's will offer additional details on the state of the consumer.</p>\n<p><b>Stocks making the biggest moves in the premarket:</b></p>\n<p><a href=\"https://laohu8.com/S/OTLY\">Oatly Group AB</a> – The oat milk producer lost 7 cents per share for its latest quarter, smaller than the 10 cents a share loss anticipated by analysts. Revenue came in below forecasts, however, and its shares tumbled 14.1% in premarket action. Oatly said it faced challenges related to various Covid-related restrictions, but that it continues to scale up production.</p>\n<p><a href=\"https://laohu8.com/S/TSLA\">Tesla Motors</a> – Tesla slid 2.1% in premarket trading after a weekly loss last week ended an 11-week winning streak. Tesla CEO <a class=\"promotion-word\" href=\"https://laohu8.com/U/4197425891462882\">Elon Musk</a> sold nearly $7 billion in stock last week.</p>\n<p><a href=\"https://laohu8.com/S/DLTR\">Dollar Tree</a> – Dollar Tree surged 8.3% in the premarket after activist investor Mantle Ridge took a stake in the discount retailer. The Wall Street Journal reports that Mantle Ridge wants Dollar Tree to take action to boost its stock price and is focusing on pricing strategies at the company’s Family Dollar chain. The news prompted Deutsche Bank to upgrade the stock to “buy” from “hold,” citing potential improvements.</p>\n<p><a href=\"https://laohu8.com/S/TSN\">Tyson</a> – The beef and poultry producer earned $2.30 per share for its fiscal fourth quarter, 27 cents a share above estimates. Revenue topped Wall Street forecasts as well. Tyson also announced a new productivity program that it says will save $1 billion annually by the end of 2024.</p>\n<p><a href=\"https://laohu8.com/S/AMT\">American Tower</a> – The communications infrastructure real estate investment trust is buying data center REITCoreSite Realty(COR) for $170 per share in cash, or about $10.1 billion. CoreSite rose 2.6% in premarket action.</p>\n<p><a href=\"https://laohu8.com/S/DE\">John Deere</a> – The heavy equipment maker and striking workers reached a third tentative contract agreement after the first two were rejected. Neither side gave details on the new agreement and it is not yet clear when a vote will take place. Workers have been off the job since Oct. 14.</p>\n<p><a href=\"https://laohu8.com/S/EVGO\">EVgo Inc.</a> – The operator of public EV charging networks saw its stock tank by 7.7% in the premarket, after Credit Suisse downgraded it to “neutral” from “outperform.” The company said a recent rally in the stock has likely priced in benefits from the infrastructure bill as well as recent partnership announcements.</p>\n<p><a href=\"https://laohu8.com/S/RDS.A\">Royal Dutch Shell PLC</a> – Royal Dutch Shell plans to scrap its dual share structure and also drop the “Royal Dutch” part of its corporate name. The announcement comes amid calls by activist investor Third Point to split up the energy giant into several companies to increase shareholder value. Class “A” shares gained 1.5% in premarket action, while class “B” shares rose 1.1%.</p>\n<p><a href=\"https://laohu8.com/S/BA\">Boeing</a> – Boeing Senior Vice President Ihssane Mounir said the jet maker is “getting close” to resuming deliveries of its 787 Dreamliner, after suspending them to deal with production issues. Mounir said the exact timing depends on the outcome of ongoing talks with regulators. The stock added 2.7% in the premarket.</p>\n<p><a href=\"https://laohu8.com/S/WOOF\">Petco Health and Wellness Company, Inc.</a> – The pet products retailer’s stock slid 2.9% in premarket trading after Jefferies downgraded it to “hold” from “buy.” Jefferies cited valuation after a 26% rise over three months, as well as challenging labor conditions in Petco’s veterinary business.</p>\n<p><a href=\"https://laohu8.com/S/CRWD\">CrowdStrike Holdings, Inc.</a> – Morgan Stanley began coverage of the cybersecurity company with an “underweight” rating, noting increasing competition and pricing pressure. Crowdstrike slid 4.6% in the premarket.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>Toplines Before US Market Open on Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Monday\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-15 21:03</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Stock futures pointed to a higher open Monday morning as investors awaited key retail sales and earnings results out from major U.S. companies later this week.<img referrerpolicy=\"no-referrer\" src=\"https://static.tigerbbs.com/9bd814193ce3a21c26ecb73c6e576fc6\" tg-height=\"511\" tg-width=\"1080\"/>At 8:00 a.m. ET, S&P 500 e-minis were up 10.75 points, or 0.23%, Nasdaq 100 e-minis were up 34.5 points, or 0.21%, and Dow e-minis  were up 118 points, or 0.33%.</p>\n<p>Investors this week are also set to receive new data from the Commerce Department on U.S. retail sales. The report is likely to show a 1.3% month-on-month jump in sales for October after a more sanguine 0.7% rise in September. And retail earnings results from major names including Walmart, Target, Home Depot and Lowe's will offer additional details on the state of the consumer.</p>\n<p><b>Stocks making the biggest moves in the premarket:</b></p>\n<p><a href=\"https://laohu8.com/S/OTLY\">Oatly Group AB</a> – The oat milk producer lost 7 cents per share for its latest quarter, smaller than the 10 cents a share loss anticipated by analysts. Revenue came in below forecasts, however, and its shares tumbled 14.1% in premarket action. Oatly said it faced challenges related to various Covid-related restrictions, but that it continues to scale up production.</p>\n<p><a href=\"https://laohu8.com/S/TSLA\">Tesla Motors</a> – Tesla slid 2.1% in premarket trading after a weekly loss last week ended an 11-week winning streak. Tesla CEO <a class=\"promotion-word\" href=\"https://laohu8.com/U/4197425891462882\">Elon Musk</a> sold nearly $7 billion in stock last week.</p>\n<p><a href=\"https://laohu8.com/S/DLTR\">Dollar Tree</a> – Dollar Tree surged 8.3% in the premarket after activist investor Mantle Ridge took a stake in the discount retailer. The Wall Street Journal reports that Mantle Ridge wants Dollar Tree to take action to boost its stock price and is focusing on pricing strategies at the company’s Family Dollar chain. The news prompted Deutsche Bank to upgrade the stock to “buy” from “hold,” citing potential improvements.</p>\n<p><a href=\"https://laohu8.com/S/TSN\">Tyson</a> – The beef and poultry producer earned $2.30 per share for its fiscal fourth quarter, 27 cents a share above estimates. Revenue topped Wall Street forecasts as well. Tyson also announced a new productivity program that it says will save $1 billion annually by the end of 2024.</p>\n<p><a href=\"https://laohu8.com/S/AMT\">American Tower</a> – The communications infrastructure real estate investment trust is buying data center REITCoreSite Realty(COR) for $170 per share in cash, or about $10.1 billion. CoreSite rose 2.6% in premarket action.</p>\n<p><a href=\"https://laohu8.com/S/DE\">John Deere</a> – The heavy equipment maker and striking workers reached a third tentative contract agreement after the first two were rejected. Neither side gave details on the new agreement and it is not yet clear when a vote will take place. Workers have been off the job since Oct. 14.</p>\n<p><a href=\"https://laohu8.com/S/EVGO\">EVgo Inc.</a> – The operator of public EV charging networks saw its stock tank by 7.7% in the premarket, after Credit Suisse downgraded it to “neutral” from “outperform.” The company said a recent rally in the stock has likely priced in benefits from the infrastructure bill as well as recent partnership announcements.</p>\n<p><a href=\"https://laohu8.com/S/RDS.A\">Royal Dutch Shell PLC</a> – Royal Dutch Shell plans to scrap its dual share structure and also drop the “Royal Dutch” part of its corporate name. The announcement comes amid calls by activist investor Third Point to split up the energy giant into several companies to increase shareholder value. Class “A” shares gained 1.5% in premarket action, while class “B” shares rose 1.1%.</p>\n<p><a href=\"https://laohu8.com/S/BA\">Boeing</a> – Boeing Senior Vice President Ihssane Mounir said the jet maker is “getting close” to resuming deliveries of its 787 Dreamliner, after suspending them to deal with production issues. Mounir said the exact timing depends on the outcome of ongoing talks with regulators. The stock added 2.7% in the premarket.</p>\n<p><a href=\"https://laohu8.com/S/WOOF\">Petco Health and Wellness Company, Inc.</a> – The pet products retailer’s stock slid 2.9% in premarket trading after Jefferies downgraded it to “hold” from “buy.” Jefferies cited valuation after a 26% rise over three months, as well as challenging labor conditions in Petco’s veterinary business.</p>\n<p><a href=\"https://laohu8.com/S/CRWD\">CrowdStrike Holdings, Inc.</a> – Morgan Stanley began coverage of the cybersecurity company with an “underweight” rating, noting increasing competition and pricing pressure. Crowdstrike slid 4.6% in the premarket.</p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1124063419","content_text":"Stock futures pointed to a higher open Monday morning as investors awaited key retail sales and earnings results out from major U.S. companies later this week.At 8:00 a.m. ET, S&P 500 e-minis were up 10.75 points, or 0.23%, Nasdaq 100 e-minis were up 34.5 points, or 0.21%, and Dow e-minis  were up 118 points, or 0.33%.\nInvestors this week are also set to receive new data from the Commerce Department on U.S. retail sales. The report is likely to show a 1.3% month-on-month jump in sales for October after a more sanguine 0.7% rise in September. And retail earnings results from major names including Walmart, Target, Home Depot and Lowe's will offer additional details on the state of the consumer.\nStocks making the biggest moves in the premarket:\nOatly Group AB – The oat milk producer lost 7 cents per share for its latest quarter, smaller than the 10 cents a share loss anticipated by analysts. Revenue came in below forecasts, however, and its shares tumbled 14.1% in premarket action. Oatly said it faced challenges related to various Covid-related restrictions, but that it continues to scale up production.\nTesla Motors – Tesla slid 2.1% in premarket trading after a weekly loss last week ended an 11-week winning streak. Tesla CEO Elon Musk sold nearly $7 billion in stock last week.\nDollar Tree – Dollar Tree surged 8.3% in the premarket after activist investor Mantle Ridge took a stake in the discount retailer. The Wall Street Journal reports that Mantle Ridge wants Dollar Tree to take action to boost its stock price and is focusing on pricing strategies at the company’s Family Dollar chain. The news prompted Deutsche Bank to upgrade the stock to “buy” from “hold,” citing potential improvements.\nTyson – The beef and poultry producer earned $2.30 per share for its fiscal fourth quarter, 27 cents a share above estimates. Revenue topped Wall Street forecasts as well. Tyson also announced a new productivity program that it says will save $1 billion annually by the end of 2024.\nAmerican Tower – The communications infrastructure real estate investment trust is buying data center REITCoreSite Realty(COR) for $170 per share in cash, or about $10.1 billion. CoreSite rose 2.6% in premarket action.\nJohn Deere – The heavy equipment maker and striking workers reached a third tentative contract agreement after the first two were rejected. Neither side gave details on the new agreement and it is not yet clear when a vote will take place. Workers have been off the job since Oct. 14.\nEVgo Inc. – The operator of public EV charging networks saw its stock tank by 7.7% in the premarket, after Credit Suisse downgraded it to “neutral” from “outperform.” The company said a recent rally in the stock has likely priced in benefits from the infrastructure bill as well as recent partnership announcements.\nRoyal Dutch Shell PLC – Royal Dutch Shell plans to scrap its dual share structure and also drop the “Royal Dutch” part of its corporate name. The announcement comes amid calls by activist investor Third Point to split up the energy giant into several companies to increase shareholder value. Class “A” shares gained 1.5% in premarket action, while class “B” shares rose 1.1%.\nBoeing – Boeing Senior Vice President Ihssane Mounir said the jet maker is “getting close” to resuming deliveries of its 787 Dreamliner, after suspending them to deal with production issues. Mounir said the exact timing depends on the outcome of ongoing talks with regulators. The stock added 2.7% in the premarket.\nPetco Health and Wellness Company, Inc. – The pet products retailer’s stock slid 2.9% in premarket trading after Jefferies downgraded it to “hold” from “buy.” Jefferies cited valuation after a 26% rise over three months, as well as challenging labor conditions in Petco’s veterinary business.\nCrowdStrike Holdings, Inc. – Morgan Stanley began coverage of the cybersecurity company with an “underweight” rating, noting increasing competition and pricing pressure. Crowdstrike slid 4.6% in the premarket.","news_type":1},"isVote":1,"tweetType":1,"viewCount":245,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":858526644,"gmtCreate":1635086915828,"gmtModify":1635086916088,"author":{"id":"4089812543711440","authorId":"4089812543711440","name":"Tiramisu2020","avatar":"https://static.tigerbbs.com/c7923aecbb67682b46eed9d583bc08c3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089812543711440","authorIdStr":"4089812543711440"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/858526644","repostId":"1174514229","repostType":4,"repost":{"id":"1174514229","kind":"news","pubTimestamp":1635035471,"share":"https://www.laohu8.com/m/news/1174514229?lang=&edition=full","pubTime":"2021-10-24 08:31","market":"us","language":"en","title":"US IPO Week Ahead: Semiconductors, energy storage, designer apparel, and more in a 12 IPO week","url":"https://stock-news.laohu8.com/highlight/detail?id=1174514229","media":"Renaissance Capital","summary":"The IPO market continues to stay busy with 12 IPOs schedule to raise $6.8 billion in the week ahead.","content":"<html><body><p>The IPO market continues to stay busy with 12 IPOs schedule to raise $6.8 billion in the week ahead.</p>\n<p>Semiconductor foundry <b>GlobalFoundries</b>(GFS) plans to raise $2.4 billion at a $24.6 billion market cap. Backed by Abu Dhabi’s Mubadala, US-based GlobalFoundries is one of the world’s leading specialty semiconductor foundries. Unprofitable with lumpy growth, the company states that it is the only scaled pure-play foundry with a global footprint that is not based in China.</p>\n<p>Enterprise cloud data management platform <b>Informatica</b>(INFA) plans to raise $885 million at an $8.7 billion market cap. This company provides data integration services on its AI-powered platform to over 5,700 customers through both licenses and subscriptions. Although it will be highly leveraged post-IPO, Informatica is a recognized leader in the global data management market and saw strong subscription ARR growth in the 1H21.</p>\n<p>Energy storage provider <b>Fluence Energy</b>(FLNC) plans to raise $698 million at a $3.8 billion market cap. Formed by Siemens and AES, this company sells energy storage products and services to utilities, independent power producers, project developers, and commercial and industrial customers. Fast growing but unprofitable, Fluence Energy deployed 942 MW of storage products as of 6/30/21.</p>\n<p>Revenue cycle management platform <b>Ensemble Health Partners</b>(ENSB) plans to raise $605 million at a $3.6 billion market cap. This platform provides revenue cycle management solutions to the healthcare industry. Profitable with accelerating growth in the 1H21, Ensemble Health has over $20 billion in annual client net patient revenue under management.</p>\n<p>Hiring solutions provider <b>HireRight Holdings</b>(HRT) plans to raise $500 million at a $1.8 billion market cap. This company provides background checks, verification, identification, monitoring, and drug and health screening services to over 40,000 customers. HireRight was profitable on an EBIT basis in the 1H21, though cash flow swung negative.</p>\n<p>Online education marketplace <b>Udemy</b>(UDMY) plans to raise $406 million at a $4.3 billion market cap. This education platform provides over 183,000 courses in 75 languages to over 44 million customers in over 180 countries. Growing but unprofitable, Udemy has registered more than 73 million users since its inception.</p>\n<p>Chinese drug in-licensor <b>LianBio</b>(LIAN) plans to raise $325 million at a $1.8 billion market cap. Focused on China and other Asian markets, this biopharmaceutical company develops and commercializes drugs for a variety of indications. LianBio’s pipeline currently consists of nine product candidates across five different therapeutics areas.</p>\n<p><b>Rent the Runway</b>(RENT) plans to raise $293 million at a $1.4 billion market cap. This apparel rental company originally focused on a-la-carte rentals of dresses for events, but has gradually transitioned to mostly generating revenue from monthly subscription boxes. While the company has seen active subscribers and revenue rebound in the last two quarters, it is unprofitable and leveraged post-IPO.</p>\n<p>Aesthetic medical device maker <b>Candela Medical</b>(CDLA) plans to raise $250 million at a $1.7 billion market cap. Selling products directly in 18 countries and indirectly in 66 countries, this company develops medical devices for elective aesthetic procedures. Despite being hard hit by the pandemic, Candela Medical saw strong growth and turned profitable in the 1H21.</p>\n<p>Fire pit brand <b>Solo Brands</b>(DTC) plans to raise $200 million at a $1.5 billion market cap. Solo Brands sells fire pits, camp stoves, and other outdoor gear through its DTC platform. Fast growing and profitable, this outdoor e-commerce has an installed base of more than 2.3 million customers.</p>\n<p>Body contouring provider <b>AirSculpt Technologies</b>(AIRS) plans to raise $160 million at an $886 million market cap. This company provides minimally-invasive body contouring procedures through 16 centers across 13 states in the US. AirSculpt Technologies is profitable with solid growth, and has seen an increase in same-center case volume as a result of lessening effects of COVID-19.</p>\n<p>Technology firm <b>Arteris</b>(AIP) plans to raise $75 million at a $555 million market cap. This technology company develops and licenses interconnect intellectual property that manages the on-chip communications in System-on-Chip semiconductor devices. Arteris is unprofitable but saw growth accelerate in the 1H21.</p>\n<p><img referrerpolicy=\"no-referrer\" src=\"https://static.tigerbbs.com/99c3b0173e59f4e69ff484c12bd137e7\" tg-height=\"704\" tg-width=\"1270\"/><img referrerpolicy=\"no-referrer\" src=\"https://static.tigerbbs.com/64e34b3c49a856e99ba64a2d57410844\" tg-height=\"582\" tg-width=\"1272\"/></p>\n<p>Street research is expected for six companies, and lock-up periods will be expiring for up to 12 companies.</p>\n<p><b>IPO Market Snapshot</b></p>\n<p>The Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 10/22/21, the Renaissance IPO Index was up 8.2% year-to-date, while the S&P 500 was up 21.1%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Uber Technologies (UBER) and Moderna (MRNA). The Renaissance International IPO Index was down 15.8% year-to-date, while the ACWX was up 9.1%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Meituan-Dianping and SoftBank.</p></body></html>","source":"lsy1603787993745","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>US IPO Week Ahead: Semiconductors, energy storage, designer apparel, and more in a 12 IPO week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Week Ahead: Semiconductors, energy storage, designer apparel, and more in a 12 IPO week\n</h2>\n<h4 class=\"meta\">\n\n\n2021-10-24 08:31 GMT+8   <a href=\"https://www.renaissancecapital.com/IPO-Center/News/87676/US-IPO-Week-Ahead-Semiconductors-energy-storage-designer-apparel-and-more-i\"><strong>Renaissance Capital</strong></a>\n</h4>\n</header>\n<article>\n<div>\n<p>The IPO market continues to stay busy with 12 IPOs schedule to raise $6.8 billion in the week ahead.\nSemiconductor foundry GlobalFoundries(GFS) plans to raise $2.4 billion at a $24.6 billion market ...</p>\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/87676/US-IPO-Week-Ahead-Semiconductors-energy-storage-designer-apparel-and-more-i\">Web Link</a>\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"HRT":"HireRight Holdings Corp.","AIRS":"Airsculpt Technologies","AIP":"Arteris, Inc.",".IXIC":"NASDAQ Composite","GFS":"GLOBALFOUNDRIES Inc.","INFA":"Informatica Inc.","RENT":"Rent the Runway, Inc.",".SPX":"S&P 500 Index","UDMY":"Udemy, Inc.","FLNC":"Fluence Energy, Inc.","DTC":"Solo Brands, Inc.",".DJI":"道琼斯"},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/87676/US-IPO-Week-Ahead-Semiconductors-energy-storage-designer-apparel-and-more-i","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1174514229","content_text":"The IPO market continues to stay busy with 12 IPOs schedule to raise $6.8 billion in the week ahead.\nSemiconductor foundry GlobalFoundries(GFS) plans to raise $2.4 billion at a $24.6 billion market cap. Backed by Abu Dhabi’s Mubadala, US-based GlobalFoundries is one of the world’s leading specialty semiconductor foundries. Unprofitable with lumpy growth, the company states that it is the only scaled pure-play foundry with a global footprint that is not based in China.\nEnterprise cloud data management platform Informatica(INFA) plans to raise $885 million at an $8.7 billion market cap. This company provides data integration services on its AI-powered platform to over 5,700 customers through both licenses and subscriptions. Although it will be highly leveraged post-IPO, Informatica is a recognized leader in the global data management market and saw strong subscription ARR growth in the 1H21.\nEnergy storage provider Fluence Energy(FLNC) plans to raise $698 million at a $3.8 billion market cap. Formed by Siemens and AES, this company sells energy storage products and services to utilities, independent power producers, project developers, and commercial and industrial customers. Fast growing but unprofitable, Fluence Energy deployed 942 MW of storage products as of 6/30/21.\nRevenue cycle management platform Ensemble Health Partners(ENSB) plans to raise $605 million at a $3.6 billion market cap. This platform provides revenue cycle management solutions to the healthcare industry. Profitable with accelerating growth in the 1H21, Ensemble Health has over $20 billion in annual client net patient revenue under management.\nHiring solutions provider HireRight Holdings(HRT) plans to raise $500 million at a $1.8 billion market cap. This company provides background checks, verification, identification, monitoring, and drug and health screening services to over 40,000 customers. HireRight was profitable on an EBIT basis in the 1H21, though cash flow swung negative.\nOnline education marketplace Udemy(UDMY) plans to raise $406 million at a $4.3 billion market cap. This education platform provides over 183,000 courses in 75 languages to over 44 million customers in over 180 countries. Growing but unprofitable, Udemy has registered more than 73 million users since its inception.\nChinese drug in-licensor LianBio(LIAN) plans to raise $325 million at a $1.8 billion market cap. Focused on China and other Asian markets, this biopharmaceutical company develops and commercializes drugs for a variety of indications. LianBio’s pipeline currently consists of nine product candidates across five different therapeutics areas.\nRent the Runway(RENT) plans to raise $293 million at a $1.4 billion market cap. This apparel rental company originally focused on a-la-carte rentals of dresses for events, but has gradually transitioned to mostly generating revenue from monthly subscription boxes. While the company has seen active subscribers and revenue rebound in the last two quarters, it is unprofitable and leveraged post-IPO.\nAesthetic medical device maker Candela Medical(CDLA) plans to raise $250 million at a $1.7 billion market cap. Selling products directly in 18 countries and indirectly in 66 countries, this company develops medical devices for elective aesthetic procedures. Despite being hard hit by the pandemic, Candela Medical saw strong growth and turned profitable in the 1H21.\nFire pit brand Solo Brands(DTC) plans to raise $200 million at a $1.5 billion market cap. Solo Brands sells fire pits, camp stoves, and other outdoor gear through its DTC platform. Fast growing and profitable, this outdoor e-commerce has an installed base of more than 2.3 million customers.\nBody contouring provider AirSculpt Technologies(AIRS) plans to raise $160 million at an $886 million market cap. This company provides minimally-invasive body contouring procedures through 16 centers across 13 states in the US. AirSculpt Technologies is profitable with solid growth, and has seen an increase in same-center case volume as a result of lessening effects of COVID-19.\nTechnology firm Arteris(AIP) plans to raise $75 million at a $555 million market cap. This technology company develops and licenses interconnect intellectual property that manages the on-chip communications in System-on-Chip semiconductor devices. Arteris is unprofitable but saw growth accelerate in the 1H21.\n\nStreet research is expected for six companies, and lock-up periods will be expiring for up to 12 companies.\nIPO Market Snapshot\nThe Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 10/22/21, the Renaissance IPO Index was up 8.2% year-to-date, while the S&P 500 was up 21.1%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Uber Technologies (UBER) and Moderna (MRNA). The Renaissance International IPO Index was down 15.8% year-to-date, while the ACWX was up 9.1%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Meituan-Dianping and SoftBank.","news_type":1},"isVote":1,"tweetType":1,"viewCount":240,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":867004963,"gmtCreate":1633157954748,"gmtModify":1633157954974,"author":{"id":"4089812543711440","authorId":"4089812543711440","name":"Tiramisu2020","avatar":"https://static.tigerbbs.com/c7923aecbb67682b46eed9d583bc08c3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089812543711440","authorIdStr":"4089812543711440"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/867004963","repostId":"2172618769","repostType":4,"isVote":1,"tweetType":1,"viewCount":347,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":889032532,"gmtCreate":1631089856626,"gmtModify":1631888660527,"author":{"id":"4089812543711440","authorId":"4089812543711440","name":"Tiramisu2020","avatar":"https://static.tigerbbs.com/c7923aecbb67682b46eed9d583bc08c3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089812543711440","authorIdStr":"4089812543711440"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/889032532","repostId":"1186834181","repostType":4,"isVote":1,"tweetType":1,"viewCount":272,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":807227021,"gmtCreate":1628040047363,"gmtModify":1633754153934,"author":{"id":"4089812543711440","authorId":"4089812543711440","name":"Tiramisu2020","avatar":"https://static.tigerbbs.com/c7923aecbb67682b46eed9d583bc08c3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089812543711440","authorIdStr":"4089812543711440"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/807227021","repostId":"2156312793","repostType":4,"isVote":1,"tweetType":1,"viewCount":239,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":690652320,"gmtCreate":1639665843861,"gmtModify":1639665848339,"author":{"id":"4089812543711440","authorId":"4089812543711440","name":"Tiramisu2020","avatar":"https://static.tigerbbs.com/c7923aecbb67682b46eed9d583bc08c3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089812543711440","authorIdStr":"4089812543711440"},"themes":[],"htmlText":"Cool&nbsp;","listText":"Cool&nbsp;","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/690652320","repostId":"2191943705","repostType":4,"isVote":1,"tweetType":1,"viewCount":227,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877023831,"gmtCreate":1637845930466,"gmtModify":1637845930567,"author":{"id":"4089812543711440","authorId":"4089812543711440","name":"Tiramisu2020","avatar":"https://static.tigerbbs.com/c7923aecbb67682b46eed9d583bc08c3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089812543711440","authorIdStr":"4089812543711440"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/877023831","repostId":"2185354679","repostType":4,"isVote":1,"tweetType":1,"viewCount":168,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":827619555,"gmtCreate":1634457775398,"gmtModify":1634457775702,"author":{"id":"4089812543711440","authorId":"4089812543711440","name":"Tiramisu2020","avatar":"https://static.tigerbbs.com/c7923aecbb67682b46eed9d583bc08c3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089812543711440","authorIdStr":"4089812543711440"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/827619555","repostId":"2175146556","repostType":4,"isVote":1,"tweetType":1,"viewCount":81,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":828731608,"gmtCreate":1633943872219,"gmtModify":1633943872303,"author":{"id":"4089812543711440","authorId":"4089812543711440","name":"Tiramisu2020","avatar":"https://static.tigerbbs.com/c7923aecbb67682b46eed9d583bc08c3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089812543711440","authorIdStr":"4089812543711440"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/828731608","repostId":"2174979104","repostType":4,"isVote":1,"tweetType":1,"viewCount":313,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":828807819,"gmtCreate":1633878510762,"gmtModify":1633878510889,"author":{"id":"4089812543711440","authorId":"4089812543711440","name":"Tiramisu2020","avatar":"https://static.tigerbbs.com/c7923aecbb67682b46eed9d583bc08c3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089812543711440","authorIdStr":"4089812543711440"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/828807819","repostId":"2174920514","repostType":4,"isVote":1,"tweetType":1,"viewCount":109,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":864882214,"gmtCreate":1633088938387,"gmtModify":1633088938603,"author":{"id":"4089812543711440","authorId":"4089812543711440","name":"Tiramisu2020","avatar":"https://static.tigerbbs.com/c7923aecbb67682b46eed9d583bc08c3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089812543711440","authorIdStr":"4089812543711440"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/864882214","repostId":"1199143925","repostType":4,"repost":{"id":"1199143925","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1633078771,"share":"https://www.laohu8.com/m/news/1199143925?lang=&edition=full","pubTime":"2021-10-01 16:59","market":"us","language":"en","title":"Top 10 stocks that Wall Street’s picks for Q4","url":"https://stock-news.laohu8.com/highlight/detail?id=1199143925","media":"Tiger Newspress","summary":"To find the names Wall Street thinks could take the market higher in th fourth quarter, CNBC Pro ide","content":"<html><body><p>To find the names Wall Street thinks could take the market higher in th fourth quarter, CNBC Pro identified the stocks with at least 70% of analysts say to buy. We then found the top 10 stocks from that pool ranked by consensus 12-month price target upside.</p>\n<p>Take a look at CNBC Pro’s list.<img height=\"auto\" referrerpolicy=\"no-referrer\" src=\"https://static.tigerbbs.com/5ae083b97e4feaf3496a1e1d77d78429\" tg-height=\"1466\" tg-width=\"1360\" width=\"100%\"/>Topping the list for potential upside is News Corp, the parent company of The Wall Street Journal-publisher Dow Jones. Analysts on average see the stock rallying 37.4% in the next 12-months. The stock is also outperforming the market this year, rising 33% compared with the S&P 500′s 16% gain.</p>\n<p>Alaska Air Group is the most liked stock on the Street from the screen. The airline stock has a buy rating from 93% of analysts covering the name. Analysts think Alaska Air can rise 27.7% in the next year.</p>\n<p>Power generator company Generac makes CNBC Pro’s screen and has the best year-to-date performance out of the list. The stock has gained nearly 80% as of Wednesday’s close. Wall Street thinks Generac has more room to run with consensus potential upside of 25.4%.</p>\n<p>Other names to make CNBC Pro’s screen include General Motors, T-Mobile and PayPal.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>Top 10 stocks that Wall Street’s picks for Q4</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop 10 stocks that Wall Street’s picks for Q4\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-10-01 16:59</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>To find the names Wall Street thinks could take the market higher in th fourth quarter, CNBC Pro identified the stocks with at least 70% of analysts say to buy. We then found the top 10 stocks from that pool ranked by consensus 12-month price target upside.</p>\n<p>Take a look at CNBC Pro’s list.<img height=\"auto\" referrerpolicy=\"no-referrer\" src=\"https://static.tigerbbs.com/5ae083b97e4feaf3496a1e1d77d78429\" tg-height=\"1466\" tg-width=\"1360\" width=\"100%\"/>Topping the list for potential upside is News Corp, the parent company of The Wall Street Journal-publisher Dow Jones. Analysts on average see the stock rallying 37.4% in the next 12-months. The stock is also outperforming the market this year, rising 33% compared with the S&P 500′s 16% gain.</p>\n<p>Alaska Air Group is the most liked stock on the Street from the screen. The airline stock has a buy rating from 93% of analysts covering the name. Analysts think Alaska Air can rise 27.7% in the next year.</p>\n<p>Power generator company Generac makes CNBC Pro’s screen and has the best year-to-date performance out of the list. The stock has gained nearly 80% as of Wednesday’s close. Wall Street thinks Generac has more room to run with consensus potential upside of 25.4%.</p>\n<p>Other names to make CNBC Pro’s screen include General Motors, T-Mobile and PayPal.</p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NWSA":"新闻集团","GM":"通用汽车","TMUS":"T-Mobile US Inc"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1199143925","content_text":"To find the names Wall Street thinks could take the market higher in th fourth quarter, CNBC Pro identified the stocks with at least 70% of analysts say to buy. We then found the top 10 stocks from that pool ranked by consensus 12-month price target upside.\nTake a look at CNBC Pro’s list.Topping the list for potential upside is News Corp, the parent company of The Wall Street Journal-publisher Dow Jones. Analysts on average see the stock rallying 37.4% in the next 12-months. The stock is also outperforming the market this year, rising 33% compared with the S&P 500′s 16% gain.\nAlaska Air Group is the most liked stock on the Street from the screen. The airline stock has a buy rating from 93% of analysts covering the name. Analysts think Alaska Air can rise 27.7% in the next year.\nPower generator company Generac makes CNBC Pro’s screen and has the best year-to-date performance out of the list. The stock has gained nearly 80% as of Wednesday’s close. Wall Street thinks Generac has more room to run with consensus potential upside of 25.4%.\nOther names to make CNBC Pro’s screen include General Motors, T-Mobile and PayPal.","news_type":1},"isVote":1,"tweetType":1,"viewCount":229,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":813710702,"gmtCreate":1630245886306,"gmtModify":1704957417505,"author":{"id":"4089812543711440","authorId":"4089812543711440","name":"Tiramisu2020","avatar":"https://static.tigerbbs.com/c7923aecbb67682b46eed9d583bc08c3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089812543711440","authorIdStr":"4089812543711440"},"themes":[],"htmlText":"Latest","listText":"Latest","text":"Latest","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/813710702","repostId":"1129129956","repostType":4,"repost":{"id":"1129129956","kind":"news","pubTimestamp":1630201285,"share":"https://www.laohu8.com/m/news/1129129956?lang=&edition=full","pubTime":"2021-08-29 09:41","market":"us","language":"en","title":"This Unloved Tech Stock Could Make You Rich One Day","url":"https://stock-news.laohu8.com/highlight/detail?id=1129129956","media":"Motley Fool","summary":"The iBuying business is a race to grow larger, and Opendoor is winning.The company is growing at a rate that is two years ahead of what management projected just a year earlier.The market is bearish on virtually all SPACs, making Opendoor a bargain that could eventually bring huge returns.Real estate iBuying company Opendoor Technologieshas been executing at a high level in the three quarters since coming public via a special purpose acquisition company  merger. In a race to disrupt residential ","content":"<html><body><p>Key Points</p>\n<ul>\n<li>The iBuying business is a race to grow larger, and Opendoor is winning.</li>\n<li>The company is growing at a rate that is two years ahead of what management projected just a year earlier.</li>\n<li>The market is bearish on virtually all SPACs, making Opendoor a bargain that could eventually bring huge returns.</li>\n</ul>\n<p></p>\n<p>Real estate iBuying company <b>Opendoor Technologies</b>(NASDAQ:OPEN)has been executing at a high level in the three quarters since coming public via a special purpose acquisition company (SPAC) merger. In a race to disrupt residential real estate, one of the largest markets in the world, Opendoor's long-term potential could bring big returns for patient investors.</p>\n<p>Despite the upside, the market hasn't yet appreciated Opendoor's accomplishments; the stock is down more than 50% from its highs. There are three important clues that Opendoor could be a compelling investment idea for bold investors.</p>\n<h3>1. Opendoor is winning the iBuying battle</h3>\n<p>The traditional home-buying process in the United States is slow and handled by multiple parties, including agents, lawyers, inspectors, and bankers. This creates a lot of back and forth paperwork and drags the process out to more than 30 days, on average.</p>\n<p>Opendoor pioneered the concept of \"iBuying,\" where the buying and selling of a house are digitized, and a company like Opendoor works directly with sellers to provide them with a cash offer and a digital closing process. The company then resells the house on the market. The iBuying process cuts out agents and some of the fees associated with traditional closings, such as agent commissions. Opendoor then resells the house on the market and charges a service fee of up to 5% on the transaction.</p>\n<p>After seeing Opendoor steadily grow with its iBuying concept, competitors have also begun to offer iBuying services, including <b>Zillow Group</b> and Offerpad. Because of how capital intensive the business is (a lot of money is needed to buy and sell thousands of houses) and how price competitive the housing market is, these companies are racing to get as big as possible. As the companies buy and sell more homes, they have the ability to become more profitable by leveraging outsourced contractors to save money, and its pricing algorithm improves as it sees more transactions.</p>\n<p>According to iBuyerStats, a website dedicated to tracking the competitors found in iBuying, Opendoor has consistently had the most housing inventory available for sale. It currently has roughly 3,300 houses for sale, 53% more than Zillow and more than four times as many as Offerpad.</p>\n<h3>2. Revenue growth is ahead of schedule</h3>\n<p>When companies go public viaSPACmerger, they lay out a public presentation of their business, often including long-term growth projections. Opendoor laid out its pre-merger investor presentation about a year ago, in September 2020.</p>\n<p>Fast forward to the company's recent 2021 Q2 earnings call. CEO and founder Eric Wu said on the earnings call, \"... based on our current progress, our second half revenue run rate is on track to exceed our 2023 target, a full two years ahead of plan.\"</p>\n<p>In other words, if Opendoor were to operate for 12 months at the level the business currently is, it would surpass the $9.8 billion in revenue it projected for 2023. This is an underlooked point because if Opendoor is already two years ahead of its original growth curve, where will it be by 2023? Sure, a dip in the housing market or other events could disrupt the company's speed of growth, but Opendoor is showing the world that the business is operating at a high level.</p>\n<h3>3. SPACs are out of favor with the market... opportunity?</h3>\n<p>Investors have overlooked this strong performance, focusing instead on the fact that Opendoor joined the public market via SPAC merger. It has hardly mattered what operating results or earnings have looked like for former SPACs; the stock market has been selling off virtually all SPAC-based stocks for several months now.</p>\n<p>Investors have been spooked by a handful of \"bad apple\" companies turning up fraudulent, and other companies have wildly missed on the projections they made before going public. These instances have burned those involved, and investors have taken a much more cautious attitude toward SPACs as a whole.</p>\n<p>But if companies like Opendoor keep blowing away estimates, the market is likely to come around eventually. When it does, the stock price could move aggressively. If we take Eric Wu's comments about revenue and assume that Opendoor does sales of $10 billion in 2022 (in other words, Opendoor stops growing and maintains its current pace over the following year), the stock currently trades at aprice-to-sales(P/S) ratio of just 1.0. That's a bargain-bin valuation.</p>\n<p>Competitor Zillow Group trades at a P/S ratio of more than 3, reflecting Opendoor's discount as a former SPAC.</p>\n<h3>Here's the bottom line</h3>\n<p>Real estate is a huge market, and it's a complicated industry because of the clash between traditional agents and the \"new kids\" on the block trying to bring technology into homebuying. It's too early to say that Opendoor will become the \"<b>Amazon</b>\" of home buying, but what seems certain is that the company is poised to be a big player in real estate's future if it keeps performing like this.</p>\n<p></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>This Unloved Tech Stock Could Make You Rich One Day</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThis Unloved Tech Stock Could Make You Rich One Day\n</h2>\n<h4 class=\"meta\">\n\n\n2021-08-29 09:41 GMT+8   <a href=\"https://www.fool.com/investing/2021/08/28/this-unloved-tech-stock-may-make-you-rich-one-day/\"><strong>Motley Fool</strong></a>\n</h4>\n</header>\n<article>\n<div>\n<p>Key Points\n\nThe iBuying business is a race to grow larger, and Opendoor is winning.\nThe company is growing at a rate that is two years ahead of what management projected just a year earlier.\nThe ...</p>\n<a href=\"https://www.fool.com/investing/2021/08/28/this-unloved-tech-stock-may-make-you-rich-one-day/\">Web Link</a>\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OPEN":"Opendoor Technologies Inc"},"source_url":"https://www.fool.com/investing/2021/08/28/this-unloved-tech-stock-may-make-you-rich-one-day/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1129129956","content_text":"Key Points\n\nThe iBuying business is a race to grow larger, and Opendoor is winning.\nThe company is growing at a rate that is two years ahead of what management projected just a year earlier.\nThe market is bearish on virtually all SPACs, making Opendoor a bargain that could eventually bring huge returns.\n\n\nReal estate iBuying company Opendoor Technologies(NASDAQ:OPEN)has been executing at a high level in the three quarters since coming public via a special purpose acquisition company (SPAC) merger. In a race to disrupt residential real estate, one of the largest markets in the world, Opendoor's long-term potential could bring big returns for patient investors.\nDespite the upside, the market hasn't yet appreciated Opendoor's accomplishments; the stock is down more than 50% from its highs. There are three important clues that Opendoor could be a compelling investment idea for bold investors.\n1. Opendoor is winning the iBuying battle\nThe traditional home-buying process in the United States is slow and handled by multiple parties, including agents, lawyers, inspectors, and bankers. This creates a lot of back and forth paperwork and drags the process out to more than 30 days, on average.\nOpendoor pioneered the concept of \"iBuying,\" where the buying and selling of a house are digitized, and a company like Opendoor works directly with sellers to provide them with a cash offer and a digital closing process. The company then resells the house on the market. The iBuying process cuts out agents and some of the fees associated with traditional closings, such as agent commissions. Opendoor then resells the house on the market and charges a service fee of up to 5% on the transaction.\nAfter seeing Opendoor steadily grow with its iBuying concept, competitors have also begun to offer iBuying services, including Zillow Group and Offerpad. Because of how capital intensive the business is (a lot of money is needed to buy and sell thousands of houses) and how price competitive the housing market is, these companies are racing to get as big as possible. As the companies buy and sell more homes, they have the ability to become more profitable by leveraging outsourced contractors to save money, and its pricing algorithm improves as it sees more transactions.\nAccording to iBuyerStats, a website dedicated to tracking the competitors found in iBuying, Opendoor has consistently had the most housing inventory available for sale. It currently has roughly 3,300 houses for sale, 53% more than Zillow and more than four times as many as Offerpad.\n2. Revenue growth is ahead of schedule\nWhen companies go public viaSPACmerger, they lay out a public presentation of their business, often including long-term growth projections. Opendoor laid out its pre-merger investor presentation about a year ago, in September 2020.\nFast forward to the company's recent 2021 Q2 earnings call. CEO and founder Eric Wu said on the earnings call, \"... based on our current progress, our second half revenue run rate is on track to exceed our 2023 target, a full two years ahead of plan.\"\nIn other words, if Opendoor were to operate for 12 months at the level the business currently is, it would surpass the $9.8 billion in revenue it projected for 2023. This is an underlooked point because if Opendoor is already two years ahead of its original growth curve, where will it be by 2023? Sure, a dip in the housing market or other events could disrupt the company's speed of growth, but Opendoor is showing the world that the business is operating at a high level.\n3. SPACs are out of favor with the market... opportunity?\nInvestors have overlooked this strong performance, focusing instead on the fact that Opendoor joined the public market via SPAC merger. It has hardly mattered what operating results or earnings have looked like for former SPACs; the stock market has been selling off virtually all SPAC-based stocks for several months now.\nInvestors have been spooked by a handful of \"bad apple\" companies turning up fraudulent, and other companies have wildly missed on the projections they made before going public. These instances have burned those involved, and investors have taken a much more cautious attitude toward SPACs as a whole.\nBut if companies like Opendoor keep blowing away estimates, the market is likely to come around eventually. When it does, the stock price could move aggressively. If we take Eric Wu's comments about revenue and assume that Opendoor does sales of $10 billion in 2022 (in other words, Opendoor stops growing and maintains its current pace over the following year), the stock currently trades at aprice-to-sales(P/S) ratio of just 1.0. That's a bargain-bin valuation.\nCompetitor Zillow Group trades at a P/S ratio of more than 3, reflecting Opendoor's discount as a former SPAC.\nHere's the bottom line\nReal estate is a huge market, and it's a complicated industry because of the clash between traditional agents and the \"new kids\" on the block trying to bring technology into homebuying. It's too early to say that Opendoor will become the \"Amazon\" of home buying, but what seems certain is that the company is poised to be a big player in real estate's future if it keeps performing like this.","news_type":1},"isVote":1,"tweetType":1,"viewCount":207,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":606673251,"gmtCreate":1638878560055,"gmtModify":1638878560275,"author":{"id":"4089812543711440","authorId":"4089812543711440","name":"Tiramisu2020","avatar":"https://static.tigerbbs.com/c7923aecbb67682b46eed9d583bc08c3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089812543711440","authorIdStr":"4089812543711440"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/606673251","repostId":"1102192068","repostType":4,"isVote":1,"tweetType":1,"viewCount":307,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608323784,"gmtCreate":1638631079746,"gmtModify":1638631079910,"author":{"id":"4089812543711440","authorId":"4089812543711440","name":"Tiramisu2020","avatar":"https://static.tigerbbs.com/c7923aecbb67682b46eed9d583bc08c3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089812543711440","authorIdStr":"4089812543711440"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/608323784","repostId":"1174181873","repostType":4,"repost":{"id":"1174181873","kind":"news","pubTimestamp":1638578178,"share":"https://www.laohu8.com/m/news/1174181873?lang=&edition=full","pubTime":"2021-12-04 08:36","market":"us","language":"en","title":"US IPO Week Ahead: Digital banking and cloud infrastructure lead a 4 IPO week","url":"https://stock-news.laohu8.com/highlight/detail?id=1174181873","media":"renaissancecap...","summary":"The IPO market is expected to pick up in the week ahead with four IPOs scheduled to raise $3.7 billi","content":"<html><body><p>The IPO market is expected to pick up in the week ahead with four IPOs scheduled to raise $3.7 billion.</p>\n<p><a class=\"promotion-word\" href=\"https://laohu8.com/U/4180165723785092\">Buffett</a>-backed <b>Nu Holdings</b>(NU) plans to raise $2.5 billion at a $41.1 billion market cap. Operating as Nubank, this Brazilian online-only bank was formed in 2013 to launch a no-fees credit card offering with a mobile-first customer experience, but has since expanded to offer various other financial products. Nu has grown rapidly since its inception, with a current base of nearly 50 million customers, though revenue per customer has been falling as its base grows.</p>\n<p>Cloud infrastructure platform <b>HashiCorp</b>(HCP) plans to raise $1.1 billion at a $14.0 billion market cap. This VC-backed company provides a suite of solutions that standardize and automate the provisioning, securing, connecting, and running of cloud infrastructure at scale. While it has demonstrated rapid growth and a sticky customer base, HashiCorp is highly unprofitable due to S&M spend.</p>\n<p>Cannabis finance REIT <b>Chicago Atlantic Real Estate Finance</b>(REFI) plans to raise $106 million at a $296 million market cap. This newly-formed REIT is focused on originating, structuring, and investing in first mortgage loans and alternative structured financings secured by commercial real estate properties. Its current portfolio consists of senior loans to state-licensed operators in the cannabis industry.</p>\n<p>Canadian gold exploration company <b>Austin Gold</b>(AUST) plans to raise $15 million at a $64 million market cap. This Canadian gold exploration company currently has interests in four properties located in the state of Nevada, with just one property that it considers material at this time. Austin Gold has not generated any operating revenues to date.</p></body></html>","source":"lsy1619493174116","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>US IPO Week Ahead: Digital banking and cloud infrastructure lead a 4 IPO week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Week Ahead: Digital banking and cloud infrastructure lead a 4 IPO week\n</h2>\n<h4 class=\"meta\">\n\n\n2021-12-04 08:36 GMT+8   <a href=\"https://www.renaissancecapital.com/IPO-Center/News/89235/US-IPO-Week-Ahead-Digital-banking-and-cloud-infrastructure-lead-a-4-IPO-wee\"><strong>renaissancecap...</strong></a>\n</h4>\n</header>\n<article>\n<div>\n<p>The IPO market is expected to pick up in the week ahead with four IPOs scheduled to raise $3.7 billion.\n<a class=\"promotion-word\" href=\"https://laohu8.com/U/4180165723785092\">Buffett</a>-backed Nu Holdings(NU) plans to raise $2.5 billion at a $41.1 billion market cap. ...</p>\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/89235/US-IPO-Week-Ahead-Digital-banking-and-cloud-infrastructure-lead-a-4-IPO-wee\">Web Link</a>\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"REFI":"Chicago Atlantic Real Estate Finance, Inc.","HCP":"HashiCorp, Inc.","NU":"Nu Holdings Ltd."},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/89235/US-IPO-Week-Ahead-Digital-banking-and-cloud-infrastructure-lead-a-4-IPO-wee","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1174181873","content_text":"The IPO market is expected to pick up in the week ahead with four IPOs scheduled to raise $3.7 billion.\nBuffett-backed Nu Holdings(NU) plans to raise $2.5 billion at a $41.1 billion market cap. Operating as Nubank, this Brazilian online-only bank was formed in 2013 to launch a no-fees credit card offering with a mobile-first customer experience, but has since expanded to offer various other financial products. Nu has grown rapidly since its inception, with a current base of nearly 50 million customers, though revenue per customer has been falling as its base grows.\nCloud infrastructure platform HashiCorp(HCP) plans to raise $1.1 billion at a $14.0 billion market cap. This VC-backed company provides a suite of solutions that standardize and automate the provisioning, securing, connecting, and running of cloud infrastructure at scale. While it has demonstrated rapid growth and a sticky customer base, HashiCorp is highly unprofitable due to S&M spend.\nCannabis finance REIT Chicago Atlantic Real Estate Finance(REFI) plans to raise $106 million at a $296 million market cap. This newly-formed REIT is focused on originating, structuring, and investing in first mortgage loans and alternative structured financings secured by commercial real estate properties. Its current portfolio consists of senior loans to state-licensed operators in the cannabis industry.\nCanadian gold exploration company Austin Gold(AUST) plans to raise $15 million at a $64 million market cap. This Canadian gold exploration company currently has interests in four properties located in the state of Nevada, with just one property that it considers material at this time. Austin Gold has not generated any operating revenues to date.","news_type":1},"isVote":1,"tweetType":1,"viewCount":127,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875404916,"gmtCreate":1637677291396,"gmtModify":1637677312524,"author":{"id":"4089812543711440","authorId":"4089812543711440","name":"Tiramisu2020","avatar":"https://static.tigerbbs.com/c7923aecbb67682b46eed9d583bc08c3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089812543711440","authorIdStr":"4089812543711440"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/875404916","repostId":"2185893503","repostType":4,"isVote":1,"tweetType":1,"viewCount":184,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}